<?xml version="1.0" encoding="utf-8"?>
<Label drug="Diovan" setid="5ddba454-f3e6-43c2-a7a6-58365d297213">
<Text><Section name="BOXED WARNING SECTION" id="34066-1">
WARNING: FETAL TOXICITY 

 When pregnancy is detected, discontinue Diovan as soon as possible. (5.1) 

 Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. (5.1) 

 WARNING: FETAL TOXICITY 

 See full prescribing information for complete boxed warning. 

 When pregnancy is detected, discontinue Diovan as soon as possible. ( 5.1 ) 

 Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. ( 5.1 )</Section>
<Section name="DOSAGE &amp; ADMINISTRATION SECTION" id="34068-7">
2     DOSAGE AND ADMINISTRATION 

 * as tolerated by patient 

 Indication 

 Starting 
 D 
 ose 

 Dose Range 

 Target Maintenance Dose* 

 Adult Hypertension ( 2.1 ) 
 80 or 160 mg once daily 
 80-320 mg once daily 
 --- 

 Pediatric Hypertension (6-16 years) ( 2.2 ) 
 1.3 mg/kg once daily (up to 40 mg total) 
 1.3-2.7 mg/kg once daily (up to 40-160 mg total) 
 --- 

 Heart Failure ( 2.3 ) 
 40 mg twice daily 
 40-160 mg twice daily 
 160 mg twice daily 

 Post-Myocardial Infarction ( 2.4 ) 
 20 mg twice daily 
 20-160 mg twice daily 
 160 mg twice daily 

 2.1     Adult Hypertension

 The recommended starting dose of Diovan (valsartan) is 80 mg or 160 mg once daily when used as monotherapy in patients who are not volume-depleted. Patients requiring greater reductions may be started at the higher dose. Diovan may be used over a dose range of 80 mg to 320 mg daily, administered once a day. 
 The antihypertensive effect is substantially present within 2 weeks and maximal reduction is generally attained after 4 weeks. If additional antihypertensive effect is required over the starting dose range, the dose may be increased to a maximum of 320 mg or a diuretic may be added. Addition of a diuretic has a greater effect than dose increases beyond 80 mg. 
 No initial dosage adjustment is required for elderly patients, for patients with mild or moderate renal impairment, or for patients with mild or moderate liver insufficiency. Care should be exercised with dosing of Diovan in patients with hepatic or severe renal impairment. 
 Diovan may be administered with other antihypertensive agents. 
 Diovan may be administered with or without food. 

 2.2     Pediatric Hypertension 6 to 16 Years of Age

 For children who can swallow tablets, the usual recommended starting dose is 1.3 mg/kg once daily (up to 40 mg total). The dosage should be adjusted according to blood pressure response. Doses higher than 2.7 mg/kg (up to 160 mg) once daily have not been studied in pediatric patients 6 to 16 years old. 
 For children who cannot swallow tablets, or children for whom the calculated dosage (mg/kg) does not correspond to the available tablet strengths of Diovan, the use of a suspension is recommended. Follow the suspension preparation instructions below (see Preparation of Suspension ) to administer valsartan as a suspension. When the suspension is replaced by a tablet, the dose of valsartan may have to be increased. The exposure to valsartan with the suspension is 1.6 times greater than with the tablet. 

 No data are available in pediatric patients either undergoing dialysis or with a glomerular filtration rate &lt;30 mL/min/1.73 m 2 
 [see Use in Specific Populations (8.4)] . 

 Diovan is not recommended for patients &lt;6 years old [see Adverse Reactions (6.1), Clinical Studies (14.1)] .

 Preparation of Suspension (for 
 160 mL of a 4 
 mg/mL suspension) 

 Add 80 mL of Ora-Plus ® * oral suspending vehicle to an amber glass bottle containing 8 Diovan 80 mg tablets, and shake for a minimum of 2 minutes. Allow the suspension to stand for a minimum of 1 hour. After the standing time, shake the suspension for a minimum of 1 additional minute. Add 80 mL of Ora-Sweet SF ® * oral sweetening vehicle to the bottle and shake the suspension for at least 10 seconds to disperse the ingredients. The suspension is homogenous and can be stored for either up to 30 days at room temperature (below 30ºC/86ºF) or up to 75 days at refrigerated conditions (2ºC-8ºC/35ºF-46ºF) in the glass bottle with a child-resistant screw-cap closure. Shake the bottle well (at least 10 seconds) prior to dispensing the suspension. 
 *Ora-Sweet SF ® and Ora-Plus ® are registered trademarks of Paddock Laboratories, Inc. 

 2.3     Heart Failure 

 The recommended starting dose of Diovan is 40 mg twice daily. Uptitration to 80 mg and 160 mg twice daily should be done to the highest dose, as tolerated by the patient. Consideration should be given to reducing the dose of concomitant diuretics. The maximum daily dose administered in clinical trials is 320 mg in divided doses. 

 2.4     Post-Myocardial Infarction

 Diovan may be initiated as early as 12 hours after a myocardial infarction. The recommended starting dose of Diovan is 20 mg twice daily. Patients may be uptitrated within 7 days to 40 mg twice daily, with subsequent titrations to a target maintenance dose of 160 mg twice daily, as tolerated by the patient. If symptomatic hypotension or renal dysfunction occurs, consideration should be given to a dosage reduction. Diovan may be given with other standard post-myocardial infarction treatment, including thrombolytics, aspirin, beta-blockers, and statins.</Section>
<Section name="CONTRAINDICATIONS SECTION" id="34070-3">
4     CONTRAINDICATIONS 

 Do not use in patients with known hypersensitivity to any component.

 Do not coadminister aliskiren with Diovan in patients with diabetes [see Drug Interactions (7)] .

 Known hypersensitivity to any component; Do not coadminister aliskiren with Diovan in patients with diabetes ( 4 )</Section>
<Section name="WARNINGS AND PRECAUTIONS SECTION" id="43685-7">
5     WARNINGS AND PRECAUTIONS 

 Observe for signs and symptoms of hypotension ( 5.2 ) 

 Monitor renal function and potassium in susceptible patients ( 5.3 , 5.4 ) 

 5.1     Fetal Toxicity 

 Pregnancy Category D 

 Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death. Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations. Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death. When pregnancy is detected, discontinue Diovan as soon as possible [see Use in Specific Populations (8.1)] .

 5.2     Hypotension

 Excessive hypotension was rarely seen (0.1%) in patients with uncomplicated hypertension treated with Diovan alone. In patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients receiving high doses of diuretics, symptomatic hypotension may occur. This condition should be corrected prior to administration of Diovan, or the treatment should start under close medical supervision. 
 Caution should be observed when initiating therapy in patients with heart failure or post-myocardial infarction patients. Patients with heart failure or post-myocardial infarction patients given Diovan commonly have some reduction in blood pressure, but discontinuation of therapy because of continuing symptomatic hypotension usually is not necessary when dosing instructions are followed. In controlled trials in heart failure patients, the incidence of hypotension in valsartan-treated patients was 5.5% compared to 1.8% in placebo-treated patients. In the VALsartan In Acute myocardial iNfarcTion trial (VALIANT), hypotension in post-myocardial infarction patients led to permanent discontinuation of therapy in 1.4% of valsartan-treated patients and 0.8% of captopril-treated patients. 
 If excessive hypotension occurs, the patient should be placed in the supine position and, if necessary, given an intravenous infusion of normal saline. A transient hypotensive response is not a contraindication to further treatment, which usually can be continued without difficulty once the blood pressure has stabilized. 

 5.3     Impaired Renal Function

 Changes in renal function including acute renal failure can be caused by drugs that inhibit the renin-angiotensin system and by diuretics. Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, or volume depletion) may be at particular risk of developing acute renal failure on Diovan. Monitor renal function periodically in these patients. Consider withholding or discontinuing therapy in patients who develop a clinically significant decrease in renal function on Diovan [see Drug Interactions (7)] . 

 5.4     Hyperkalemia

 Some patients with heart failure have developed increases in potassium. These effects are usually minor and transient, and they are more likely to occur in patients with pre-existing renal impairment. Dosage reduction and/or discontinuation of Diovan may be required [see Adverse Reactions (6.1)] .</Section>
<Section name="DRUG INTERACTIONS SECTION" id="34073-7">
7     DRUG INTERACTIONS 

 No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. The valsartan-atenolol combination was more antihypertensive than either component, but it did not lower the heart rate more than atenolol alone. 
 Coadministration of valsartan and warfarin did not change the pharmacokinetics of valsartan or the time-course of the anticoagulant properties of warfarin. 

 CYP 450 Interactions: In vitro  metabolism studies indicate that CYP 450 mediated drug interactions between valsartan and coadministered drugs are unlikely because of the low extent of metabolism [see Clinical Pharmacology (12.3)] . 

 Transporters: The results from an in vitro study with human liver tissue indicate that valsartan is a substrate of the hepatic uptake transporter OATP1B1 and the hepatic efflux transporter MRP2. Coadministration of inhibitors of the uptake transporter (rifampin, cyclosporine) or efflux transporter (ritonavir) may increase the systemic exposure to valsartan. 

 Potassium: Concomitant use of valsartan with other agents that block the renin-angiotensin system, potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride), potassium supplements, salt substitutes containing potassium or other drugs that may increase potassium levels (e.g., heparin) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine. If co-medication is considered necessary, monitoring of serum potassium is advisable. 

 Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including valsartan, may result in deterioration of renal function, including possible acute renal failure. These effects are usually reversible. Monitor renal function periodically in patients receiving valsartan and NSAID therapy. 
 The antihypertensive effect of angiotensin II receptor antagonists, including valsartan, may be attenuated by NSAIDs including selective COX-2 inhibitors. 

 Dual Blockade of the Renin-Angiotensin System (RAS): Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. Most patients receiving the combination of two RAS inhibitors do not obtain any additional benefit compared to monotherapy [see Clinical Studies (14.3)] . In general, avoid combined use of RAS inhibitors. Closely monitor blood pressure, renal function and electrolytes in patients on Diovan and other agents that affect the RAS. 
 Do not coadminister aliskiren with Diovan in patients with diabetes. Avoid use of aliskiren with Diovan in patients with renal impairment (GFR &lt;60 mL/min). 

 Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists, including Diovan. Monitor serum lithium levels during concomitant use. 

 Potassium-sparing diuretics, potassium supplements or salt substitutes may lead to increases in serum potassium, and in heart failure patients, increases in serum creatinine ( 7 ) 

 NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ) 
 Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia ( 7 ) 
 Lithium: Increases in serum lithium concentrations and lithium toxicity ( 7 ) 

 7.1     Clinical Laboratory Test Findings

 In controlled clinical trials, clinically important changes in standard laboratory parameters were rarely associated with administration of Diovan. 

 Creatinine: Minor elevations in creatinine occurred in 0.8% of patients taking Diovan and 0.6% given placebo in controlled clinical trials of hypertensive patients. In heart failure trials, greater than 50% increases in creatinine were observed in 3.9% of Diovan-treated patients compared to 0.9% of placebo-treated patients. In post-myocardial infarction patients, doubling of serum creatinine was observed in 4.2% of valsartan-treated patients and 3.4% of captopril-treated patients. 

 Hemoglobin and Hematocrit: Greater than 20% decreases in hemoglobin and hematocrit were observed in 0.4% and 0.8%, respectively, of Diovan patients, compared with 0.1% and 0.1% in placebo-treated patients. One valsartan patient discontinued treatment for microcytic anemia. 

 Liver Function Tests: Occasional elevations (greater than 150%) of liver chemistries occurred in Diovan-treated patients. Three patients (&lt;0.1%) treated with valsartan discontinued treatment for elevated liver chemistries. 

 Neutropenia: Neutropenia was observed in 1.9% of patients treated with Diovan and 0.8% of patients treated with placebo. 

 Serum Potassium: In hypertensive patients, greater than 20% increases in serum potassium were observed in 4.4% of Diovan-treated patients compared to 2.9% of placebo-treated patients. In heart failure patients, greater than 20% increases in serum potassium were observed in 10.0% of Diovan-treated patients compared to 5.1% of placebo-treated patients. 

 Blood Urea Nitrogen (BUN): In heart failure trials, greater than 50% increases in BUN were observed in 16.6% of Diovan-treated patients compared to 6.3% of placebo-treated patients.</Section>
</Text><Sentences>
<Sentence id="245" LabelDrug="Diovan" section="34068-7">
<SentenceText>Diovan may be administered with other antihypertensive agents .</SentenceText>
</Sentence>
<Sentence id="246" LabelDrug="Diovan" section="34068-7">
<SentenceText>Diovan may be given with other standard post-myocardial infarction treatment , including thrombolytics , aspirin , beta-blockers , and statins .</SentenceText>
</Sentence>
<Sentence id="247" LabelDrug="Diovan" section="34070-3">
<SentenceText>Do not coadminister aliskiren with Diovan in patients with diabetes see Drug Interactions ( 7 ) .</SentenceText>
<Mention id="M1" type="Trigger" span="0 19" str="Do not coadminister"/>
<Mention id="M2" type="Precipitant" span="20 9" str="aliskiren" code="N0000176084"/>
<Interaction id="I1" type="Unspecified interaction" trigger="M1" precipitant="M2"/>
</Sentence>
<Sentence id="248" LabelDrug="Diovan" section="34070-3">
<SentenceText>Known hypersensitivity to any component , Do not coadminister aliskiren with Diovan in patients with diabetes ( 4 ) .</SentenceText>
<Mention id="M3" type="Trigger" span="42 19" str="Do not coadminister"/>
<Mention id="M4" type="Precipitant" span="62 9" str="aliskiren" code="N0000176084"/>
<Interaction id="I2" type="Unspecified interaction" trigger="M3" precipitant="M4"/>
</Sentence>
<Sentence id="249" LabelDrug="Diovan" section="34073-7">
<SentenceText>Avoid use of aliskiren with Diovan in patients with renal impairment ( GFR 60 mL/min ) .</SentenceText>
</Sentence>
<Sentence id="250" LabelDrug="Diovan" section="34073-7">
<SentenceText>Blood Urea Nitrogen (BUN): In heart failure trials, greater than 50% increases in BUN were observed in 16.6% of Diovan-treated patients compared to 6.3% of placebo-treated patients.</SentenceText>
</Sentence>
<Sentence id="251" LabelDrug="Diovan" section="34073-7">
<SentenceText>Closely monitor blood pressure , renal function and electrolytes in patients on Diovan and other agents that affect the RAS .</SentenceText>
<Mention id="M5" type="Trigger" span="8 7" str="monitor"/>
<Mention id="M6" type="Precipitant" span="97 26" str="agents that affect the RAS" code="NO MAP"/>
<Interaction id="I3" type="Unspecified interaction" trigger="M5" precipitant="M6"/>
</Sentence>
<Sentence id="252" LabelDrug="Diovan" section="34073-7">
<SentenceText>Coadministration of inhibitors of the uptake transporter ( rifampin , cyclosporine ) or efflux transporter ( ritonavir ) may increase the systemic exposure to valsartan .</SentenceText>
<Mention id="M15" type="Trigger" span="125 8;147 8" str="increase | exposure"/>
<Mention id="M8" type="Precipitant" span="70 12" str="cyclosporine" code="N0000007346"/>
<Mention id="M10" type="Precipitant" span="20 10;88 18" str="inhibitors | efflux transporter" code="NO MAP"/>
<Mention id="M12" type="Precipitant" span="20 36" str="inhibitors of the uptake transporter" code="NO MAP"/>
<Mention id="M14" type="Precipitant" span="59 8" str="rifampin" code="N0000006026"/>
<Mention id="M16" type="Precipitant" span="109 9" str="ritonavir" code="N0000007423"/>
<Interaction id="I4" type="Pharmacokinetic interaction" trigger="M15" precipitant="M8" effect="C54355"/>
<Interaction id="I5" type="Pharmacokinetic interaction" trigger="M15" precipitant="M10" effect="C54355"/>
<Interaction id="I6" type="Pharmacokinetic interaction" trigger="M15" precipitant="M12" effect="C54355"/>
<Interaction id="I7" type="Pharmacokinetic interaction" trigger="M15" precipitant="M14" effect="C54355"/>
<Interaction id="I8" type="Pharmacokinetic interaction" trigger="M15" precipitant="M16" effect="C54355"/>
</Sentence>
<Sentence id="252" LabelDrug="Diovan" section="34073-7">
<SentenceText>Coadministration of inhibitors of the uptake transporter ( rifampin , cyclosporine ) or efflux transporter ( ritonavir ) may increase the systemic exposure to valsartan .</SentenceText>
<Mention id="M25" type="Trigger" span="125 8;147 8" str="increase | exposure"/>
<Mention id="M18" type="Precipitant" span="70 12" str="cyclosporine" code="N0000007346"/>
<Mention id="M20" type="Precipitant" span="20 10;88 18" str="inhibitors | efflux transporter" code="NO MAP"/>
<Mention id="M22" type="Precipitant" span="20 36" str="inhibitors of the uptake transporter" code="NO MAP"/>
<Mention id="M24" type="Precipitant" span="59 8" str="rifampin" code="N0000006026"/>
<Mention id="M26" type="Precipitant" span="109 9" str="ritonavir" code="N0000007423"/>
<Interaction id="I9" type="Pharmacokinetic interaction" trigger="M25" precipitant="M18" effect="C54355"/>
<Interaction id="I10" type="Pharmacokinetic interaction" trigger="M25" precipitant="M20" effect="C54355"/>
<Interaction id="I11" type="Pharmacokinetic interaction" trigger="M25" precipitant="M22" effect="C54355"/>
<Interaction id="I12" type="Pharmacokinetic interaction" trigger="M25" precipitant="M24" effect="C54355"/>
<Interaction id="I13" type="Pharmacokinetic interaction" trigger="M25" precipitant="M26" effect="C54355"/>
</Sentence>
<Sentence id="252" LabelDrug="Diovan" section="34073-7">
<SentenceText>Coadministration of inhibitors of the uptake transporter ( rifampin , cyclosporine ) or efflux transporter ( ritonavir ) may increase the systemic exposure to valsartan .</SentenceText>
<Mention id="M35" type="Trigger" span="125 8;147 8" str="increase | exposure"/>
<Mention id="M28" type="Precipitant" span="70 12" str="cyclosporine" code="N0000007346"/>
<Mention id="M30" type="Precipitant" span="20 10;88 18" str="inhibitors | efflux transporter" code="NO MAP"/>
<Mention id="M32" type="Precipitant" span="20 36" str="inhibitors of the uptake transporter" code="NO MAP"/>
<Mention id="M34" type="Precipitant" span="59 8" str="rifampin" code="N0000006026"/>
<Mention id="M36" type="Precipitant" span="109 9" str="ritonavir" code="N0000007423"/>
<Interaction id="I14" type="Pharmacokinetic interaction" trigger="M35" precipitant="M28" effect="C54355"/>
<Interaction id="I15" type="Pharmacokinetic interaction" trigger="M35" precipitant="M30" effect="C54355"/>
<Interaction id="I16" type="Pharmacokinetic interaction" trigger="M35" precipitant="M32" effect="C54355"/>
<Interaction id="I17" type="Pharmacokinetic interaction" trigger="M35" precipitant="M34" effect="C54355"/>
<Interaction id="I18" type="Pharmacokinetic interaction" trigger="M35" precipitant="M36" effect="C54355"/>
</Sentence>
<Sentence id="252" LabelDrug="Diovan" section="34073-7">
<SentenceText>Coadministration of inhibitors of the uptake transporter ( rifampin , cyclosporine ) or efflux transporter ( ritonavir ) may increase the systemic exposure to valsartan .</SentenceText>
<Mention id="M45" type="Trigger" span="125 8;147 8" str="increase | exposure"/>
<Mention id="M38" type="Precipitant" span="70 12" str="cyclosporine" code="N0000007346"/>
<Mention id="M40" type="Precipitant" span="20 10;88 18" str="inhibitors | efflux transporter" code="NO MAP"/>
<Mention id="M42" type="Precipitant" span="20 36" str="inhibitors of the uptake transporter" code="NO MAP"/>
<Mention id="M44" type="Precipitant" span="59 8" str="rifampin" code="N0000006026"/>
<Mention id="M46" type="Precipitant" span="109 9" str="ritonavir" code="N0000007423"/>
<Interaction id="I19" type="Pharmacokinetic interaction" trigger="M45" precipitant="M38" effect="C54355"/>
<Interaction id="I20" type="Pharmacokinetic interaction" trigger="M45" precipitant="M40" effect="C54355"/>
<Interaction id="I21" type="Pharmacokinetic interaction" trigger="M45" precipitant="M42" effect="C54355"/>
<Interaction id="I22" type="Pharmacokinetic interaction" trigger="M45" precipitant="M44" effect="C54355"/>
<Interaction id="I23" type="Pharmacokinetic interaction" trigger="M45" precipitant="M46" effect="C54355"/>
</Sentence>
<Sentence id="252" LabelDrug="Diovan" section="34073-7">
<SentenceText>Coadministration of inhibitors of the uptake transporter ( rifampin , cyclosporine ) or efflux transporter ( ritonavir ) may increase the systemic exposure to valsartan .</SentenceText>
<Mention id="M55" type="Trigger" span="125 8;147 8" str="increase | exposure"/>
<Mention id="M48" type="Precipitant" span="70 12" str="cyclosporine" code="N0000007346"/>
<Mention id="M50" type="Precipitant" span="20 10;88 18" str="inhibitors | efflux transporter" code="NO MAP"/>
<Mention id="M52" type="Precipitant" span="20 36" str="inhibitors of the uptake transporter" code="NO MAP"/>
<Mention id="M54" type="Precipitant" span="59 8" str="rifampin" code="N0000006026"/>
<Mention id="M56" type="Precipitant" span="109 9" str="ritonavir" code="N0000007423"/>
<Interaction id="I24" type="Pharmacokinetic interaction" trigger="M55" precipitant="M48" effect="C54355"/>
<Interaction id="I25" type="Pharmacokinetic interaction" trigger="M55" precipitant="M50" effect="C54355"/>
<Interaction id="I26" type="Pharmacokinetic interaction" trigger="M55" precipitant="M52" effect="C54355"/>
<Interaction id="I27" type="Pharmacokinetic interaction" trigger="M55" precipitant="M54" effect="C54355"/>
<Interaction id="I28" type="Pharmacokinetic interaction" trigger="M55" precipitant="M56" effect="C54355"/>
</Sentence>
<Sentence id="253" LabelDrug="Diovan" section="34073-7">
<SentenceText>Coadministration of valsartan and warfarin did not change the pharmacokinetics of valsartan or the time-course of the anticoagulant properties of warfarin .</SentenceText>
</Sentence>
<Sentence id="254" LabelDrug="Diovan" section="34073-7">
<SentenceText>Creatinine: Minor elevations in creatinine occurred in 0.8% of patients taking Diovan and 0.6% given placebo in controlled clinical trials of hypertensive patients.</SentenceText>
</Sentence>
<Sentence id="255" LabelDrug="Diovan" section="34073-7">
<SentenceText>CYP 450 Interactions: In vitro metabolism studies indicate that CYP 450 mediated drug interactions between valsartan and coadministered drugs are unlikely because of the low extent of metabolism [see Clinical Pharmacology (12.3)].</SentenceText>
</Sentence>
<Sentence id="256" LabelDrug="Diovan" section="34073-7">
<SentenceText>Do not coadminister aliskiren with Diovan in patients with diabetes .</SentenceText>
<Mention id="M57" type="Trigger" span="0 19" str="Do not coadminister"/>
<Mention id="M58" type="Precipitant" span="20 9" str="aliskiren" code="N0000176084"/>
<Interaction id="I29" type="Unspecified interaction" trigger="M57" precipitant="M58"/>
</Sentence>
<Sentence id="257" LabelDrug="Diovan" section="34073-7">
<SentenceText>Dual Blockade of the Renin-Angiotensin System (RAS): Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy.</SentenceText>
<Mention id="M69" type="Trigger" span="162 15" str="increased risks"/>
<Mention id="M60" type="Precipitant" span="114 14" str="ACE inhibitors" code="N0000029130"/>
<Mention id="M71" type="SpecificInteraction" span="181 11" str="hypotension " code="45007003: Low blood pressure (disorder)"/>
<Mention id="M72" type="SpecificInteraction" span="194 12" str=" hyperkalemia " code=" 14140009: Hyperkalemia (disorder)"/>
<Mention id="M73" type="SpecificInteraction" span="212 25" str=" changes in renal function" code=" 39539005: Abnormal renal function (finding)"/>
<Mention id="M65" type="Precipitant" span="133 9" str="aliskiren" code="N0000176084"/>
<Mention id="M70" type="Precipitant" span="83 29" str="angiotensin receptor blockers" code="N0000000070"/>
<Interaction id="I30" type="Pharmacodynamic interaction" trigger="M69" precipitant="M60" effect="M71;M72;M73"/>
<Interaction id="I31" type="Pharmacodynamic interaction" trigger="M69" precipitant="M65" effect="M71;M72;M73"/>
<Interaction id="I32" type="Pharmacodynamic interaction" trigger="M69" precipitant="M70" effect="M71;M72;M73"/>
</Sentence>
<Sentence id="257" LabelDrug="Diovan" section="34073-7">
<SentenceText>Dual Blockade of the Renin-Angiotensin System (RAS): Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy.</SentenceText>
<Mention id="M84" type="Trigger" span="162 15" str="increased risks"/>
<Mention id="M75" type="Precipitant" span="114 14" str="ACE inhibitors" code="N0000029130"/>
<Mention id="M86" type="SpecificInteraction" span="181 11" str="hypotension " code="45007003: Low blood pressure (disorder)"/>
<Mention id="M87" type="SpecificInteraction" span="194 12" str=" hyperkalemia " code=" 14140009: Hyperkalemia (disorder)"/>
<Mention id="M88" type="SpecificInteraction" span="212 25" str=" changes in renal function" code=" 39539005: Abnormal renal function (finding)"/>
<Mention id="M80" type="Precipitant" span="133 9" str="aliskiren" code="N0000176084"/>
<Mention id="M85" type="Precipitant" span="83 29" str="angiotensin receptor blockers" code="N0000000070"/>
<Interaction id="I33" type="Pharmacodynamic interaction" trigger="M84" precipitant="M75" effect="M86;M87;M88"/>
<Interaction id="I34" type="Pharmacodynamic interaction" trigger="M84" precipitant="M80" effect="M86;M87;M88"/>
<Interaction id="I35" type="Pharmacodynamic interaction" trigger="M84" precipitant="M85" effect="M86;M87;M88"/>
</Sentence>
<Sentence id="257" LabelDrug="Diovan" section="34073-7">
<SentenceText>Dual Blockade of the Renin-Angiotensin System (RAS): Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy.</SentenceText>
<Mention id="M99" type="Trigger" span="162 15" str="increased risks"/>
<Mention id="M90" type="Precipitant" span="114 14" str="ACE inhibitors" code="N0000029130"/>
<Mention id="M101" type="SpecificInteraction" span="181 11" str="hypotension " code="45007003: Low blood pressure (disorder)"/>
<Mention id="M102" type="SpecificInteraction" span="194 12" str=" hyperkalemia " code=" 14140009: Hyperkalemia (disorder)"/>
<Mention id="M103" type="SpecificInteraction" span="212 25" str=" changes in renal function" code=" 39539005: Abnormal renal function (finding)"/>
<Mention id="M95" type="Precipitant" span="133 9" str="aliskiren" code="N0000176084"/>
<Mention id="M100" type="Precipitant" span="83 29" str="angiotensin receptor blockers" code="N0000000070"/>
<Interaction id="I36" type="Pharmacodynamic interaction" trigger="M99" precipitant="M90" effect="M101;M102;M103"/>
<Interaction id="I37" type="Pharmacodynamic interaction" trigger="M99" precipitant="M95" effect="M101;M102;M103"/>
<Interaction id="I38" type="Pharmacodynamic interaction" trigger="M99" precipitant="M100" effect="M101;M102;M103"/>
</Sentence>
<Sentence id="258" LabelDrug="Diovan" section="34073-7">
<SentenceText>Hemoglobin and Hematocrit: Greater than 20% decreases in hemoglobin and hematocrit were observed in 0.4% and 0.8%, respectively, of Diovan patients, compared with 0.1% and 0.1% in placebo-treated patients.</SentenceText>
</Sentence>
<Sentence id="259" LabelDrug="Diovan" section="34073-7">
<SentenceText>If co-medication is considered necessary, monitoring of serum potassium is advisable.</SentenceText>
</Sentence>
<Sentence id="260" LabelDrug="Diovan" section="34073-7">
<SentenceText>In general, avoid combined use of RAS inhibitors.</SentenceText>
<Mention id="M104" type="Trigger" span="12 5;27 3" str="avoid | use"/>
<Mention id="M105" type="Precipitant" span="34 14" str="RAS inhibitors" code="NO MAP"/>
<Interaction id="I39" type="Unspecified interaction" trigger="M104" precipitant="M105"/>
</Sentence>
<Sentence id="261" LabelDrug="Diovan" section="34073-7">
<SentenceText>In heart failure patients, greater than 20% increases in serum potassium were observed in 10.0% of Diovan-treated patients compared to 5.1% of placebo-treated patients.</SentenceText>
</Sentence>
<Sentence id="262" LabelDrug="Diovan" section="34073-7">
<SentenceText>In heart failure trials, greater than 50% increases in creatinine were observed in 3.9% of Diovan-treated patients compared to 0.9% of placebo-treated patients.</SentenceText>
</Sentence>
<Sentence id="263" LabelDrug="Diovan" section="34073-7">
<SentenceText>In post-myocardial infarction patients , doubling of serum creatinine was observed in 4.2 % of valsartan-treated patients and 3.4 % of captopril-treated patients .</SentenceText>
</Sentence>
<Sentence id="264" LabelDrug="Diovan" section="34073-7">
<SentenceText>Lithium : Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists , including Diovan .</SentenceText>
<Mention id="M106" type="Trigger" span="10 18;37 14" str="Increases in serum | concentrations "/>
<Mention id="M107" type="Trigger" span="64 8" str=" toxicity"/>
<Mention id="M108" type="Precipitant" span="29 7" str="lithium" code="N0000147892"/>
<Interaction id="I40" type="Pharmacokinetic interaction" trigger="M106;M107" precipitant="M108" effect="C54357"/>
</Sentence>
<Sentence id="265" LabelDrug="Diovan" section="34073-7">
<SentenceText>Liver Function Tests: Occasional elevations (greater than 150%) of liver chemistries occurred in Diovan-treated patients.</SentenceText>
</Sentence>
<Sentence id="266" LabelDrug="Diovan" section="34073-7">
<SentenceText>Monitor renal function periodically in patients receiving valsartan and NSAID therapy .</SentenceText>
<Mention id="M109" type="Trigger" span="0 7" str="Monitor"/>
<Mention id="M110" type="Precipitant" span="72 5" str="NSAID" code="N0000175722"/>
<Interaction id="I41" type="Unspecified interaction" trigger="M109" precipitant="M110"/>
</Sentence>
<Sentence id="267" LabelDrug="Diovan" section="34073-7">
<SentenceText>Monitor serum lithium levels during concomitant use.</SentenceText>
</Sentence>
<Sentence id="268" LabelDrug="Diovan" section="34073-7">
<SentenceText>Most patients receiving the combination of two RAS inhibitors do not obtain any additional benefit compared to monotherapy [see Clinical Studies (14.3)].</SentenceText>
</Sentence>
<Sentence id="269" LabelDrug="Diovan" section="34073-7">
<SentenceText>Neutropenia: Neutropenia was observed in 1.9% of patients treated with Diovan and 0.8% of patients treated with placebo.</SentenceText>
</Sentence>
<Sentence id="270" LabelDrug="Diovan" section="34073-7">
<SentenceText>No clinically significant pharmacokinetic interactions were observed when Diovan ( valsartan ) was coadministered with amlodipine , atenolol , cimetidine , digoxin , furosemide , glyburide , hydrochlorothiazide , or indomethacin .</SentenceText>
</Sentence>
<Sentence id="271" LabelDrug="Diovan" section="34073-7">
<SentenceText>Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors ( COX-2 Inhibitors ) : In patients who are elderly , volume-depleted ( including those on diuretic therapy ) , or with compromised renal function , coadministration of NSAIDs , including selective COX-2 inhibitors , with angiotensin II receptor antagonists , including valsartan , may result in deterioration of renal function , including possible acute renal failure .</SentenceText>
<Mention id="M119" type="SpecificInteraction" span="435 19" str="acute renal failure" code="14669001: Acute renal failure syndrome (disorder)"/>
<Mention id="M115" type="Precipitant" span="284 16" str="COX-2 inhibitors" code="N0000008288"/>
<Mention id="M122" type="SpecificInteraction" span="382 31" str="deterioration of renal function" code="314983004: Deteriorating renal function (finding)"/>
<Mention id="M121" type="Precipitant" span="255 6" str="NSAIDs" code="N0000175722"/>
<Interaction id="I42" type="Pharmacodynamic interaction" trigger="M119" precipitant="M115" effect="M119"/>
<Interaction id="I43" type="Pharmacodynamic interaction" trigger="M122" precipitant="M115" effect="M122"/>
<Interaction id="I44" type="Pharmacodynamic interaction" trigger="M119" precipitant="M121" effect="M119"/>
<Interaction id="I45" type="Pharmacodynamic interaction" trigger="M122" precipitant="M121" effect="M122"/>
</Sentence>
<Sentence id="271" LabelDrug="Diovan" section="34073-7">
<SentenceText>Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors ( COX-2 Inhibitors ) : In patients who are elderly , volume-depleted ( including those on diuretic therapy ) , or with compromised renal function , coadministration of NSAIDs , including selective COX-2 inhibitors , with angiotensin II receptor antagonists , including valsartan , may result in deterioration of renal function , including possible acute renal failure .</SentenceText>
<Mention id="M131" type="SpecificInteraction" span="435 19" str="acute renal failure" code="14669001: Acute renal failure syndrome (disorder)"/>
<Mention id="M127" type="Precipitant" span="284 16" str="COX-2 inhibitors" code="N0000008288"/>
<Mention id="M134" type="SpecificInteraction" span="382 31" str="deterioration of renal function" code="314983004: Deteriorating renal function (finding)"/>
<Mention id="M133" type="Precipitant" span="255 6" str="NSAIDs" code="N0000175722"/>
<Interaction id="I46" type="Pharmacodynamic interaction" trigger="M131" precipitant="M127" effect="M131"/>
<Interaction id="I47" type="Pharmacodynamic interaction" trigger="M134" precipitant="M127" effect="M134"/>
<Interaction id="I48" type="Pharmacodynamic interaction" trigger="M131" precipitant="M133" effect="M131"/>
<Interaction id="I49" type="Pharmacodynamic interaction" trigger="M134" precipitant="M133" effect="M134"/>
</Sentence>
<Sentence id="271" LabelDrug="Diovan" section="34073-7">
<SentenceText>Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors ( COX-2 Inhibitors ) : In patients who are elderly , volume-depleted ( including those on diuretic therapy ) , or with compromised renal function , coadministration of NSAIDs , including selective COX-2 inhibitors , with angiotensin II receptor antagonists , including valsartan , may result in deterioration of renal function , including possible acute renal failure .</SentenceText>
<Mention id="M143" type="SpecificInteraction" span="435 19" str="acute renal failure" code="14669001: Acute renal failure syndrome (disorder)"/>
<Mention id="M139" type="Precipitant" span="284 16" str="COX-2 inhibitors" code="N0000008288"/>
<Mention id="M146" type="SpecificInteraction" span="382 31" str="deterioration of renal function" code="314983004: Deteriorating renal function (finding)"/>
<Mention id="M145" type="Precipitant" span="255 6" str="NSAIDs" code="N0000175722"/>
<Interaction id="I50" type="Pharmacodynamic interaction" trigger="M143" precipitant="M139" effect="M143"/>
<Interaction id="I51" type="Pharmacodynamic interaction" trigger="M146" precipitant="M139" effect="M146"/>
<Interaction id="I52" type="Pharmacodynamic interaction" trigger="M143" precipitant="M145" effect="M143"/>
<Interaction id="I53" type="Pharmacodynamic interaction" trigger="M146" precipitant="M145" effect="M146"/>
</Sentence>
<Sentence id="271" LabelDrug="Diovan" section="34073-7">
<SentenceText>Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors ( COX-2 Inhibitors ) : In patients who are elderly , volume-depleted ( including those on diuretic therapy ) , or with compromised renal function , coadministration of NSAIDs , including selective COX-2 inhibitors , with angiotensin II receptor antagonists , including valsartan , may result in deterioration of renal function , including possible acute renal failure .</SentenceText>
<Mention id="M155" type="SpecificInteraction" span="435 19" str="acute renal failure" code="14669001: Acute renal failure syndrome (disorder)"/>
<Mention id="M151" type="Precipitant" span="284 16" str="COX-2 inhibitors" code="N0000008288"/>
<Mention id="M158" type="SpecificInteraction" span="382 31" str="deterioration of renal function" code="314983004: Deteriorating renal function (finding)"/>
<Mention id="M157" type="Precipitant" span="255 6" str="NSAIDs" code="N0000175722"/>
<Interaction id="I54" type="Pharmacodynamic interaction" trigger="M155" precipitant="M151" effect="M155"/>
<Interaction id="I55" type="Pharmacodynamic interaction" trigger="M158" precipitant="M151" effect="M158"/>
<Interaction id="I56" type="Pharmacodynamic interaction" trigger="M155" precipitant="M157" effect="M155"/>
<Interaction id="I57" type="Pharmacodynamic interaction" trigger="M158" precipitant="M157" effect="M158"/>
</Sentence>
<Sentence id="272" LabelDrug="Diovan" section="34073-7">
<SentenceText>One valsartan patient discontinued treatment for microcytic anemia.</SentenceText>
</Sentence>
<Sentence id="273" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine .</SentenceText>
<Mention id="M210" type="Trigger" span="318 17" str="lead to increases"/>
<Mention id="M163" type="Precipitant" span="52 46" str="agents that block the renin-angiotensin system" code="n0000175561"/>
<Mention id="M209" type="SpecificInteraction" span="388 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M212" type="SpecificInteraction" span="326 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M169" type="Precipitant" span="169 9" str="amiloride" code="N0000006772"/>
<Mention id="M175" type="Precipitant" span="254 40" str="drugs that may increase potassium levels" code="NO MAP"/>
<Mention id="M181" type="Precipitant" span="304 7" str="heparin" code="N0000006341"/>
<Mention id="M187" type="Precipitant" span="183 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M193" type="Precipitant" span="101 27" str="potassium-sparing diuretics" code="N0000175418"/>
<Mention id="M199" type="Precipitant" span="207 37" str="salt substitutes containing potassium" code="NO MAP"/>
<Mention id="M205" type="Precipitant" span="138 14" str="spironolactone" code="N0000005900"/>
<Mention id="M211" type="Precipitant" span="155 11" str="triamterene" code="N0000005985"/>
<Interaction id="I58" type="Pharmacodynamic interaction" trigger="M210" precipitant="M163" effect="M209"/>
<Interaction id="I59" type="Pharmacodynamic interaction" trigger="M210" precipitant="M163" effect="M212"/>
<Interaction id="I60" type="Pharmacodynamic interaction" trigger="M210" precipitant="M169" effect="M209"/>
<Interaction id="I61" type="Pharmacodynamic interaction" trigger="M210" precipitant="M169" effect="M212"/>
<Interaction id="I62" type="Pharmacodynamic interaction" trigger="M210" precipitant="M175" effect="M209"/>
<Interaction id="I63" type="Pharmacodynamic interaction" trigger="M210" precipitant="M175" effect="M212"/>
<Interaction id="I64" type="Pharmacodynamic interaction" trigger="M210" precipitant="M181" effect="M209"/>
<Interaction id="I65" type="Pharmacodynamic interaction" trigger="M210" precipitant="M181" effect="M212"/>
<Interaction id="I66" type="Pharmacodynamic interaction" trigger="M210" precipitant="M187" effect="M209"/>
<Interaction id="I67" type="Pharmacodynamic interaction" trigger="M210" precipitant="M187" effect="M212"/>
<Interaction id="I68" type="Pharmacodynamic interaction" trigger="M210" precipitant="M193" effect="M209"/>
<Interaction id="I69" type="Pharmacodynamic interaction" trigger="M210" precipitant="M193" effect="M212"/>
<Interaction id="I70" type="Pharmacodynamic interaction" trigger="M210" precipitant="M199" effect="M209"/>
<Interaction id="I71" type="Pharmacodynamic interaction" trigger="M210" precipitant="M199" effect="M212"/>
<Interaction id="I72" type="Pharmacodynamic interaction" trigger="M210" precipitant="M205" effect="M209"/>
<Interaction id="I73" type="Pharmacodynamic interaction" trigger="M210" precipitant="M205" effect="M212"/>
<Interaction id="I74" type="Pharmacodynamic interaction" trigger="M210" precipitant="M211" effect="M209"/>
<Interaction id="I75" type="Pharmacodynamic interaction" trigger="M210" precipitant="M211" effect="M212"/>
</Sentence>
<Sentence id="273" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine .</SentenceText>
<Mention id="M264" type="Trigger" span="318 17" str="lead to increases"/>
<Mention id="M217" type="Precipitant" span="52 46" str="agents that block the renin-angiotensin system" code="n0000175561"/>
<Mention id="M263" type="SpecificInteraction" span="388 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M266" type="SpecificInteraction" span="326 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M223" type="Precipitant" span="169 9" str="amiloride" code="N0000006772"/>
<Mention id="M229" type="Precipitant" span="254 40" str="drugs that may increase potassium levels" code="NO MAP"/>
<Mention id="M235" type="Precipitant" span="304 7" str="heparin" code="N0000006341"/>
<Mention id="M241" type="Precipitant" span="183 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M247" type="Precipitant" span="101 27" str="potassium-sparing diuretics" code="N0000175418"/>
<Mention id="M253" type="Precipitant" span="207 37" str="salt substitutes containing potassium" code="NO MAP"/>
<Mention id="M259" type="Precipitant" span="138 14" str="spironolactone" code="N0000005900"/>
<Mention id="M265" type="Precipitant" span="155 11" str="triamterene" code="N0000005985"/>
<Interaction id="I76" type="Pharmacodynamic interaction" trigger="M264" precipitant="M217" effect="M263"/>
<Interaction id="I77" type="Pharmacodynamic interaction" trigger="M264" precipitant="M217" effect="M266"/>
<Interaction id="I78" type="Pharmacodynamic interaction" trigger="M264" precipitant="M223" effect="M263"/>
<Interaction id="I79" type="Pharmacodynamic interaction" trigger="M264" precipitant="M223" effect="M266"/>
<Interaction id="I80" type="Pharmacodynamic interaction" trigger="M264" precipitant="M229" effect="M263"/>
<Interaction id="I81" type="Pharmacodynamic interaction" trigger="M264" precipitant="M229" effect="M266"/>
<Interaction id="I82" type="Pharmacodynamic interaction" trigger="M264" precipitant="M235" effect="M263"/>
<Interaction id="I83" type="Pharmacodynamic interaction" trigger="M264" precipitant="M235" effect="M266"/>
<Interaction id="I84" type="Pharmacodynamic interaction" trigger="M264" precipitant="M241" effect="M263"/>
<Interaction id="I85" type="Pharmacodynamic interaction" trigger="M264" precipitant="M241" effect="M266"/>
<Interaction id="I86" type="Pharmacodynamic interaction" trigger="M264" precipitant="M247" effect="M263"/>
<Interaction id="I87" type="Pharmacodynamic interaction" trigger="M264" precipitant="M247" effect="M266"/>
<Interaction id="I88" type="Pharmacodynamic interaction" trigger="M264" precipitant="M253" effect="M263"/>
<Interaction id="I89" type="Pharmacodynamic interaction" trigger="M264" precipitant="M253" effect="M266"/>
<Interaction id="I90" type="Pharmacodynamic interaction" trigger="M264" precipitant="M259" effect="M263"/>
<Interaction id="I91" type="Pharmacodynamic interaction" trigger="M264" precipitant="M259" effect="M266"/>
<Interaction id="I92" type="Pharmacodynamic interaction" trigger="M264" precipitant="M265" effect="M263"/>
<Interaction id="I93" type="Pharmacodynamic interaction" trigger="M264" precipitant="M265" effect="M266"/>
</Sentence>
<Sentence id="273" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine .</SentenceText>
<Mention id="M318" type="Trigger" span="318 17" str="lead to increases"/>
<Mention id="M271" type="Precipitant" span="52 46" str="agents that block the renin-angiotensin system" code="n0000175561"/>
<Mention id="M317" type="SpecificInteraction" span="388 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M320" type="SpecificInteraction" span="326 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M277" type="Precipitant" span="169 9" str="amiloride" code="N0000006772"/>
<Mention id="M283" type="Precipitant" span="254 40" str="drugs that may increase potassium levels" code="NO MAP"/>
<Mention id="M289" type="Precipitant" span="304 7" str="heparin" code="N0000006341"/>
<Mention id="M295" type="Precipitant" span="183 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M301" type="Precipitant" span="101 27" str="potassium-sparing diuretics" code="N0000175418"/>
<Mention id="M307" type="Precipitant" span="207 37" str="salt substitutes containing potassium" code="NO MAP"/>
<Mention id="M313" type="Precipitant" span="138 14" str="spironolactone" code="N0000005900"/>
<Mention id="M319" type="Precipitant" span="155 11" str="triamterene" code="N0000005985"/>
<Interaction id="I94" type="Pharmacodynamic interaction" trigger="M318" precipitant="M271" effect="M317"/>
<Interaction id="I95" type="Pharmacodynamic interaction" trigger="M318" precipitant="M271" effect="M320"/>
<Interaction id="I96" type="Pharmacodynamic interaction" trigger="M318" precipitant="M277" effect="M317"/>
<Interaction id="I97" type="Pharmacodynamic interaction" trigger="M318" precipitant="M277" effect="M320"/>
<Interaction id="I98" type="Pharmacodynamic interaction" trigger="M318" precipitant="M283" effect="M317"/>
<Interaction id="I99" type="Pharmacodynamic interaction" trigger="M318" precipitant="M283" effect="M320"/>
<Interaction id="I100" type="Pharmacodynamic interaction" trigger="M318" precipitant="M289" effect="M317"/>
<Interaction id="I101" type="Pharmacodynamic interaction" trigger="M318" precipitant="M289" effect="M320"/>
<Interaction id="I102" type="Pharmacodynamic interaction" trigger="M318" precipitant="M295" effect="M317"/>
<Interaction id="I103" type="Pharmacodynamic interaction" trigger="M318" precipitant="M295" effect="M320"/>
<Interaction id="I104" type="Pharmacodynamic interaction" trigger="M318" precipitant="M301" effect="M317"/>
<Interaction id="I105" type="Pharmacodynamic interaction" trigger="M318" precipitant="M301" effect="M320"/>
<Interaction id="I106" type="Pharmacodynamic interaction" trigger="M318" precipitant="M307" effect="M317"/>
<Interaction id="I107" type="Pharmacodynamic interaction" trigger="M318" precipitant="M307" effect="M320"/>
<Interaction id="I108" type="Pharmacodynamic interaction" trigger="M318" precipitant="M313" effect="M317"/>
<Interaction id="I109" type="Pharmacodynamic interaction" trigger="M318" precipitant="M313" effect="M320"/>
<Interaction id="I110" type="Pharmacodynamic interaction" trigger="M318" precipitant="M319" effect="M317"/>
<Interaction id="I111" type="Pharmacodynamic interaction" trigger="M318" precipitant="M319" effect="M320"/>
</Sentence>
<Sentence id="273" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine .</SentenceText>
<Mention id="M372" type="Trigger" span="318 17" str="lead to increases"/>
<Mention id="M325" type="Precipitant" span="52 46" str="agents that block the renin-angiotensin system" code="n0000175561"/>
<Mention id="M371" type="SpecificInteraction" span="388 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M374" type="SpecificInteraction" span="326 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M331" type="Precipitant" span="169 9" str="amiloride" code="N0000006772"/>
<Mention id="M337" type="Precipitant" span="254 40" str="drugs that may increase potassium levels" code="NO MAP"/>
<Mention id="M343" type="Precipitant" span="304 7" str="heparin" code="N0000006341"/>
<Mention id="M349" type="Precipitant" span="183 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M355" type="Precipitant" span="101 27" str="potassium-sparing diuretics" code="N0000175418"/>
<Mention id="M361" type="Precipitant" span="207 37" str="salt substitutes containing potassium" code="NO MAP"/>
<Mention id="M367" type="Precipitant" span="138 14" str="spironolactone" code="N0000005900"/>
<Mention id="M373" type="Precipitant" span="155 11" str="triamterene" code="N0000005985"/>
<Interaction id="I112" type="Pharmacodynamic interaction" trigger="M372" precipitant="M325" effect="M371"/>
<Interaction id="I113" type="Pharmacodynamic interaction" trigger="M372" precipitant="M325" effect="M374"/>
<Interaction id="I114" type="Pharmacodynamic interaction" trigger="M372" precipitant="M331" effect="M371"/>
<Interaction id="I115" type="Pharmacodynamic interaction" trigger="M372" precipitant="M331" effect="M374"/>
<Interaction id="I116" type="Pharmacodynamic interaction" trigger="M372" precipitant="M337" effect="M371"/>
<Interaction id="I117" type="Pharmacodynamic interaction" trigger="M372" precipitant="M337" effect="M374"/>
<Interaction id="I118" type="Pharmacodynamic interaction" trigger="M372" precipitant="M343" effect="M371"/>
<Interaction id="I119" type="Pharmacodynamic interaction" trigger="M372" precipitant="M343" effect="M374"/>
<Interaction id="I120" type="Pharmacodynamic interaction" trigger="M372" precipitant="M349" effect="M371"/>
<Interaction id="I121" type="Pharmacodynamic interaction" trigger="M372" precipitant="M349" effect="M374"/>
<Interaction id="I122" type="Pharmacodynamic interaction" trigger="M372" precipitant="M355" effect="M371"/>
<Interaction id="I123" type="Pharmacodynamic interaction" trigger="M372" precipitant="M355" effect="M374"/>
<Interaction id="I124" type="Pharmacodynamic interaction" trigger="M372" precipitant="M361" effect="M371"/>
<Interaction id="I125" type="Pharmacodynamic interaction" trigger="M372" precipitant="M361" effect="M374"/>
<Interaction id="I126" type="Pharmacodynamic interaction" trigger="M372" precipitant="M367" effect="M371"/>
<Interaction id="I127" type="Pharmacodynamic interaction" trigger="M372" precipitant="M367" effect="M374"/>
<Interaction id="I128" type="Pharmacodynamic interaction" trigger="M372" precipitant="M373" effect="M371"/>
<Interaction id="I129" type="Pharmacodynamic interaction" trigger="M372" precipitant="M373" effect="M374"/>
</Sentence>
<Sentence id="273" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine .</SentenceText>
<Mention id="M426" type="Trigger" span="318 17" str="lead to increases"/>
<Mention id="M379" type="Precipitant" span="52 46" str="agents that block the renin-angiotensin system" code="n0000175561"/>
<Mention id="M425" type="SpecificInteraction" span="388 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M428" type="SpecificInteraction" span="326 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M385" type="Precipitant" span="169 9" str="amiloride" code="N0000006772"/>
<Mention id="M391" type="Precipitant" span="254 40" str="drugs that may increase potassium levels" code="NO MAP"/>
<Mention id="M397" type="Precipitant" span="304 7" str="heparin" code="N0000006341"/>
<Mention id="M403" type="Precipitant" span="183 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M409" type="Precipitant" span="101 27" str="potassium-sparing diuretics" code="N0000175418"/>
<Mention id="M415" type="Precipitant" span="207 37" str="salt substitutes containing potassium" code="NO MAP"/>
<Mention id="M421" type="Precipitant" span="138 14" str="spironolactone" code="N0000005900"/>
<Mention id="M427" type="Precipitant" span="155 11" str="triamterene" code="N0000005985"/>
<Interaction id="I130" type="Pharmacodynamic interaction" trigger="M426" precipitant="M379" effect="M425"/>
<Interaction id="I131" type="Pharmacodynamic interaction" trigger="M426" precipitant="M379" effect="M428"/>
<Interaction id="I132" type="Pharmacodynamic interaction" trigger="M426" precipitant="M385" effect="M425"/>
<Interaction id="I133" type="Pharmacodynamic interaction" trigger="M426" precipitant="M385" effect="M428"/>
<Interaction id="I134" type="Pharmacodynamic interaction" trigger="M426" precipitant="M391" effect="M425"/>
<Interaction id="I135" type="Pharmacodynamic interaction" trigger="M426" precipitant="M391" effect="M428"/>
<Interaction id="I136" type="Pharmacodynamic interaction" trigger="M426" precipitant="M397" effect="M425"/>
<Interaction id="I137" type="Pharmacodynamic interaction" trigger="M426" precipitant="M397" effect="M428"/>
<Interaction id="I138" type="Pharmacodynamic interaction" trigger="M426" precipitant="M403" effect="M425"/>
<Interaction id="I139" type="Pharmacodynamic interaction" trigger="M426" precipitant="M403" effect="M428"/>
<Interaction id="I140" type="Pharmacodynamic interaction" trigger="M426" precipitant="M409" effect="M425"/>
<Interaction id="I141" type="Pharmacodynamic interaction" trigger="M426" precipitant="M409" effect="M428"/>
<Interaction id="I142" type="Pharmacodynamic interaction" trigger="M426" precipitant="M415" effect="M425"/>
<Interaction id="I143" type="Pharmacodynamic interaction" trigger="M426" precipitant="M415" effect="M428"/>
<Interaction id="I144" type="Pharmacodynamic interaction" trigger="M426" precipitant="M421" effect="M425"/>
<Interaction id="I145" type="Pharmacodynamic interaction" trigger="M426" precipitant="M421" effect="M428"/>
<Interaction id="I146" type="Pharmacodynamic interaction" trigger="M426" precipitant="M427" effect="M425"/>
<Interaction id="I147" type="Pharmacodynamic interaction" trigger="M426" precipitant="M427" effect="M428"/>
</Sentence>
<Sentence id="273" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine .</SentenceText>
<Mention id="M480" type="Trigger" span="318 17" str="lead to increases"/>
<Mention id="M433" type="Precipitant" span="52 46" str="agents that block the renin-angiotensin system" code="n0000175561"/>
<Mention id="M479" type="SpecificInteraction" span="388 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M482" type="SpecificInteraction" span="326 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M439" type="Precipitant" span="169 9" str="amiloride" code="N0000006772"/>
<Mention id="M445" type="Precipitant" span="254 40" str="drugs that may increase potassium levels" code="NO MAP"/>
<Mention id="M451" type="Precipitant" span="304 7" str="heparin" code="N0000006341"/>
<Mention id="M457" type="Precipitant" span="183 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M463" type="Precipitant" span="101 27" str="potassium-sparing diuretics" code="N0000175418"/>
<Mention id="M469" type="Precipitant" span="207 37" str="salt substitutes containing potassium" code="NO MAP"/>
<Mention id="M475" type="Precipitant" span="138 14" str="spironolactone" code="N0000005900"/>
<Mention id="M481" type="Precipitant" span="155 11" str="triamterene" code="N0000005985"/>
<Interaction id="I148" type="Pharmacodynamic interaction" trigger="M480" precipitant="M433" effect="M479"/>
<Interaction id="I149" type="Pharmacodynamic interaction" trigger="M480" precipitant="M433" effect="M482"/>
<Interaction id="I150" type="Pharmacodynamic interaction" trigger="M480" precipitant="M439" effect="M479"/>
<Interaction id="I151" type="Pharmacodynamic interaction" trigger="M480" precipitant="M439" effect="M482"/>
<Interaction id="I152" type="Pharmacodynamic interaction" trigger="M480" precipitant="M445" effect="M479"/>
<Interaction id="I153" type="Pharmacodynamic interaction" trigger="M480" precipitant="M445" effect="M482"/>
<Interaction id="I154" type="Pharmacodynamic interaction" trigger="M480" precipitant="M451" effect="M479"/>
<Interaction id="I155" type="Pharmacodynamic interaction" trigger="M480" precipitant="M451" effect="M482"/>
<Interaction id="I156" type="Pharmacodynamic interaction" trigger="M480" precipitant="M457" effect="M479"/>
<Interaction id="I157" type="Pharmacodynamic interaction" trigger="M480" precipitant="M457" effect="M482"/>
<Interaction id="I158" type="Pharmacodynamic interaction" trigger="M480" precipitant="M463" effect="M479"/>
<Interaction id="I159" type="Pharmacodynamic interaction" trigger="M480" precipitant="M463" effect="M482"/>
<Interaction id="I160" type="Pharmacodynamic interaction" trigger="M480" precipitant="M469" effect="M479"/>
<Interaction id="I161" type="Pharmacodynamic interaction" trigger="M480" precipitant="M469" effect="M482"/>
<Interaction id="I162" type="Pharmacodynamic interaction" trigger="M480" precipitant="M475" effect="M479"/>
<Interaction id="I163" type="Pharmacodynamic interaction" trigger="M480" precipitant="M475" effect="M482"/>
<Interaction id="I164" type="Pharmacodynamic interaction" trigger="M480" precipitant="M481" effect="M479"/>
<Interaction id="I165" type="Pharmacodynamic interaction" trigger="M480" precipitant="M481" effect="M482"/>
</Sentence>
<Sentence id="273" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine .</SentenceText>
<Mention id="M534" type="Trigger" span="318 17" str="lead to increases"/>
<Mention id="M487" type="Precipitant" span="52 46" str="agents that block the renin-angiotensin system" code="n0000175561"/>
<Mention id="M533" type="SpecificInteraction" span="388 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M536" type="SpecificInteraction" span="326 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M493" type="Precipitant" span="169 9" str="amiloride" code="N0000006772"/>
<Mention id="M499" type="Precipitant" span="254 40" str="drugs that may increase potassium levels" code="NO MAP"/>
<Mention id="M505" type="Precipitant" span="304 7" str="heparin" code="N0000006341"/>
<Mention id="M511" type="Precipitant" span="183 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M517" type="Precipitant" span="101 27" str="potassium-sparing diuretics" code="N0000175418"/>
<Mention id="M523" type="Precipitant" span="207 37" str="salt substitutes containing potassium" code="NO MAP"/>
<Mention id="M529" type="Precipitant" span="138 14" str="spironolactone" code="N0000005900"/>
<Mention id="M535" type="Precipitant" span="155 11" str="triamterene" code="N0000005985"/>
<Interaction id="I166" type="Pharmacodynamic interaction" trigger="M534" precipitant="M487" effect="M533"/>
<Interaction id="I167" type="Pharmacodynamic interaction" trigger="M534" precipitant="M487" effect="M536"/>
<Interaction id="I168" type="Pharmacodynamic interaction" trigger="M534" precipitant="M493" effect="M533"/>
<Interaction id="I169" type="Pharmacodynamic interaction" trigger="M534" precipitant="M493" effect="M536"/>
<Interaction id="I170" type="Pharmacodynamic interaction" trigger="M534" precipitant="M499" effect="M533"/>
<Interaction id="I171" type="Pharmacodynamic interaction" trigger="M534" precipitant="M499" effect="M536"/>
<Interaction id="I172" type="Pharmacodynamic interaction" trigger="M534" precipitant="M505" effect="M533"/>
<Interaction id="I173" type="Pharmacodynamic interaction" trigger="M534" precipitant="M505" effect="M536"/>
<Interaction id="I174" type="Pharmacodynamic interaction" trigger="M534" precipitant="M511" effect="M533"/>
<Interaction id="I175" type="Pharmacodynamic interaction" trigger="M534" precipitant="M511" effect="M536"/>
<Interaction id="I176" type="Pharmacodynamic interaction" trigger="M534" precipitant="M517" effect="M533"/>
<Interaction id="I177" type="Pharmacodynamic interaction" trigger="M534" precipitant="M517" effect="M536"/>
<Interaction id="I178" type="Pharmacodynamic interaction" trigger="M534" precipitant="M523" effect="M533"/>
<Interaction id="I179" type="Pharmacodynamic interaction" trigger="M534" precipitant="M523" effect="M536"/>
<Interaction id="I180" type="Pharmacodynamic interaction" trigger="M534" precipitant="M529" effect="M533"/>
<Interaction id="I181" type="Pharmacodynamic interaction" trigger="M534" precipitant="M529" effect="M536"/>
<Interaction id="I182" type="Pharmacodynamic interaction" trigger="M534" precipitant="M535" effect="M533"/>
<Interaction id="I183" type="Pharmacodynamic interaction" trigger="M534" precipitant="M535" effect="M536"/>
</Sentence>
<Sentence id="273" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine .</SentenceText>
<Mention id="M588" type="Trigger" span="318 17" str="lead to increases"/>
<Mention id="M541" type="Precipitant" span="52 46" str="agents that block the renin-angiotensin system" code="n0000175561"/>
<Mention id="M587" type="SpecificInteraction" span="388 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M590" type="SpecificInteraction" span="326 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M547" type="Precipitant" span="169 9" str="amiloride" code="N0000006772"/>
<Mention id="M553" type="Precipitant" span="254 40" str="drugs that may increase potassium levels" code="NO MAP"/>
<Mention id="M559" type="Precipitant" span="304 7" str="heparin" code="N0000006341"/>
<Mention id="M565" type="Precipitant" span="183 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M571" type="Precipitant" span="101 27" str="potassium-sparing diuretics" code="N0000175418"/>
<Mention id="M577" type="Precipitant" span="207 37" str="salt substitutes containing potassium" code="NO MAP"/>
<Mention id="M583" type="Precipitant" span="138 14" str="spironolactone" code="N0000005900"/>
<Mention id="M589" type="Precipitant" span="155 11" str="triamterene" code="N0000005985"/>
<Interaction id="I184" type="Pharmacodynamic interaction" trigger="M588" precipitant="M541" effect="M587"/>
<Interaction id="I185" type="Pharmacodynamic interaction" trigger="M588" precipitant="M541" effect="M590"/>
<Interaction id="I186" type="Pharmacodynamic interaction" trigger="M588" precipitant="M547" effect="M587"/>
<Interaction id="I187" type="Pharmacodynamic interaction" trigger="M588" precipitant="M547" effect="M590"/>
<Interaction id="I188" type="Pharmacodynamic interaction" trigger="M588" precipitant="M553" effect="M587"/>
<Interaction id="I189" type="Pharmacodynamic interaction" trigger="M588" precipitant="M553" effect="M590"/>
<Interaction id="I190" type="Pharmacodynamic interaction" trigger="M588" precipitant="M559" effect="M587"/>
<Interaction id="I191" type="Pharmacodynamic interaction" trigger="M588" precipitant="M559" effect="M590"/>
<Interaction id="I192" type="Pharmacodynamic interaction" trigger="M588" precipitant="M565" effect="M587"/>
<Interaction id="I193" type="Pharmacodynamic interaction" trigger="M588" precipitant="M565" effect="M590"/>
<Interaction id="I194" type="Pharmacodynamic interaction" trigger="M588" precipitant="M571" effect="M587"/>
<Interaction id="I195" type="Pharmacodynamic interaction" trigger="M588" precipitant="M571" effect="M590"/>
<Interaction id="I196" type="Pharmacodynamic interaction" trigger="M588" precipitant="M577" effect="M587"/>
<Interaction id="I197" type="Pharmacodynamic interaction" trigger="M588" precipitant="M577" effect="M590"/>
<Interaction id="I198" type="Pharmacodynamic interaction" trigger="M588" precipitant="M583" effect="M587"/>
<Interaction id="I199" type="Pharmacodynamic interaction" trigger="M588" precipitant="M583" effect="M590"/>
<Interaction id="I200" type="Pharmacodynamic interaction" trigger="M588" precipitant="M589" effect="M587"/>
<Interaction id="I201" type="Pharmacodynamic interaction" trigger="M588" precipitant="M589" effect="M590"/>
</Sentence>
<Sentence id="273" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine .</SentenceText>
<Mention id="M642" type="Trigger" span="318 17" str="lead to increases"/>
<Mention id="M595" type="Precipitant" span="52 46" str="agents that block the renin-angiotensin system" code="n0000175561"/>
<Mention id="M641" type="SpecificInteraction" span="388 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M644" type="SpecificInteraction" span="326 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M601" type="Precipitant" span="169 9" str="amiloride" code="N0000006772"/>
<Mention id="M607" type="Precipitant" span="254 40" str="drugs that may increase potassium levels" code="NO MAP"/>
<Mention id="M613" type="Precipitant" span="304 7" str="heparin" code="N0000006341"/>
<Mention id="M619" type="Precipitant" span="183 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M625" type="Precipitant" span="101 27" str="potassium-sparing diuretics" code="N0000175418"/>
<Mention id="M631" type="Precipitant" span="207 37" str="salt substitutes containing potassium" code="NO MAP"/>
<Mention id="M637" type="Precipitant" span="138 14" str="spironolactone" code="N0000005900"/>
<Mention id="M643" type="Precipitant" span="155 11" str="triamterene" code="N0000005985"/>
<Interaction id="I202" type="Pharmacodynamic interaction" trigger="M642" precipitant="M595" effect="M641"/>
<Interaction id="I203" type="Pharmacodynamic interaction" trigger="M642" precipitant="M595" effect="M644"/>
<Interaction id="I204" type="Pharmacodynamic interaction" trigger="M642" precipitant="M601" effect="M641"/>
<Interaction id="I205" type="Pharmacodynamic interaction" trigger="M642" precipitant="M601" effect="M644"/>
<Interaction id="I206" type="Pharmacodynamic interaction" trigger="M642" precipitant="M607" effect="M641"/>
<Interaction id="I207" type="Pharmacodynamic interaction" trigger="M642" precipitant="M607" effect="M644"/>
<Interaction id="I208" type="Pharmacodynamic interaction" trigger="M642" precipitant="M613" effect="M641"/>
<Interaction id="I209" type="Pharmacodynamic interaction" trigger="M642" precipitant="M613" effect="M644"/>
<Interaction id="I210" type="Pharmacodynamic interaction" trigger="M642" precipitant="M619" effect="M641"/>
<Interaction id="I211" type="Pharmacodynamic interaction" trigger="M642" precipitant="M619" effect="M644"/>
<Interaction id="I212" type="Pharmacodynamic interaction" trigger="M642" precipitant="M625" effect="M641"/>
<Interaction id="I213" type="Pharmacodynamic interaction" trigger="M642" precipitant="M625" effect="M644"/>
<Interaction id="I214" type="Pharmacodynamic interaction" trigger="M642" precipitant="M631" effect="M641"/>
<Interaction id="I215" type="Pharmacodynamic interaction" trigger="M642" precipitant="M631" effect="M644"/>
<Interaction id="I216" type="Pharmacodynamic interaction" trigger="M642" precipitant="M637" effect="M641"/>
<Interaction id="I217" type="Pharmacodynamic interaction" trigger="M642" precipitant="M637" effect="M644"/>
<Interaction id="I218" type="Pharmacodynamic interaction" trigger="M642" precipitant="M643" effect="M641"/>
<Interaction id="I219" type="Pharmacodynamic interaction" trigger="M642" precipitant="M643" effect="M644"/>
</Sentence>
<Sentence id="273" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine .</SentenceText>
<Mention id="M696" type="Trigger" span="318 17" str="lead to increases"/>
<Mention id="M649" type="Precipitant" span="52 46" str="agents that block the renin-angiotensin system" code="n0000175561"/>
<Mention id="M695" type="SpecificInteraction" span="388 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M698" type="SpecificInteraction" span="326 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M655" type="Precipitant" span="169 9" str="amiloride" code="N0000006772"/>
<Mention id="M661" type="Precipitant" span="254 40" str="drugs that may increase potassium levels" code="NO MAP"/>
<Mention id="M667" type="Precipitant" span="304 7" str="heparin" code="N0000006341"/>
<Mention id="M673" type="Precipitant" span="183 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M679" type="Precipitant" span="101 27" str="potassium-sparing diuretics" code="N0000175418"/>
<Mention id="M685" type="Precipitant" span="207 37" str="salt substitutes containing potassium" code="NO MAP"/>
<Mention id="M691" type="Precipitant" span="138 14" str="spironolactone" code="N0000005900"/>
<Mention id="M697" type="Precipitant" span="155 11" str="triamterene" code="N0000005985"/>
<Interaction id="I220" type="Pharmacodynamic interaction" trigger="M696" precipitant="M649" effect="M695"/>
<Interaction id="I221" type="Pharmacodynamic interaction" trigger="M696" precipitant="M649" effect="M698"/>
<Interaction id="I222" type="Pharmacodynamic interaction" trigger="M696" precipitant="M655" effect="M695"/>
<Interaction id="I223" type="Pharmacodynamic interaction" trigger="M696" precipitant="M655" effect="M698"/>
<Interaction id="I224" type="Pharmacodynamic interaction" trigger="M696" precipitant="M661" effect="M695"/>
<Interaction id="I225" type="Pharmacodynamic interaction" trigger="M696" precipitant="M661" effect="M698"/>
<Interaction id="I226" type="Pharmacodynamic interaction" trigger="M696" precipitant="M667" effect="M695"/>
<Interaction id="I227" type="Pharmacodynamic interaction" trigger="M696" precipitant="M667" effect="M698"/>
<Interaction id="I228" type="Pharmacodynamic interaction" trigger="M696" precipitant="M673" effect="M695"/>
<Interaction id="I229" type="Pharmacodynamic interaction" trigger="M696" precipitant="M673" effect="M698"/>
<Interaction id="I230" type="Pharmacodynamic interaction" trigger="M696" precipitant="M679" effect="M695"/>
<Interaction id="I231" type="Pharmacodynamic interaction" trigger="M696" precipitant="M679" effect="M698"/>
<Interaction id="I232" type="Pharmacodynamic interaction" trigger="M696" precipitant="M685" effect="M695"/>
<Interaction id="I233" type="Pharmacodynamic interaction" trigger="M696" precipitant="M685" effect="M698"/>
<Interaction id="I234" type="Pharmacodynamic interaction" trigger="M696" precipitant="M691" effect="M695"/>
<Interaction id="I235" type="Pharmacodynamic interaction" trigger="M696" precipitant="M691" effect="M698"/>
<Interaction id="I236" type="Pharmacodynamic interaction" trigger="M696" precipitant="M697" effect="M695"/>
<Interaction id="I237" type="Pharmacodynamic interaction" trigger="M696" precipitant="M697" effect="M698"/>
</Sentence>
<Sentence id="273" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine .</SentenceText>
<Mention id="M750" type="Trigger" span="318 17" str="lead to increases"/>
<Mention id="M703" type="Precipitant" span="52 46" str="agents that block the renin-angiotensin system" code="n0000175561"/>
<Mention id="M749" type="SpecificInteraction" span="388 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M752" type="SpecificInteraction" span="326 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M709" type="Precipitant" span="169 9" str="amiloride" code="N0000006772"/>
<Mention id="M715" type="Precipitant" span="254 40" str="drugs that may increase potassium levels" code="NO MAP"/>
<Mention id="M721" type="Precipitant" span="304 7" str="heparin" code="N0000006341"/>
<Mention id="M727" type="Precipitant" span="183 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M733" type="Precipitant" span="101 27" str="potassium-sparing diuretics" code="N0000175418"/>
<Mention id="M739" type="Precipitant" span="207 37" str="salt substitutes containing potassium" code="NO MAP"/>
<Mention id="M745" type="Precipitant" span="138 14" str="spironolactone" code="N0000005900"/>
<Mention id="M751" type="Precipitant" span="155 11" str="triamterene" code="N0000005985"/>
<Interaction id="I238" type="Pharmacodynamic interaction" trigger="M750" precipitant="M703" effect="M749"/>
<Interaction id="I239" type="Pharmacodynamic interaction" trigger="M750" precipitant="M703" effect="M752"/>
<Interaction id="I240" type="Pharmacodynamic interaction" trigger="M750" precipitant="M709" effect="M749"/>
<Interaction id="I241" type="Pharmacodynamic interaction" trigger="M750" precipitant="M709" effect="M752"/>
<Interaction id="I242" type="Pharmacodynamic interaction" trigger="M750" precipitant="M715" effect="M749"/>
<Interaction id="I243" type="Pharmacodynamic interaction" trigger="M750" precipitant="M715" effect="M752"/>
<Interaction id="I244" type="Pharmacodynamic interaction" trigger="M750" precipitant="M721" effect="M749"/>
<Interaction id="I245" type="Pharmacodynamic interaction" trigger="M750" precipitant="M721" effect="M752"/>
<Interaction id="I246" type="Pharmacodynamic interaction" trigger="M750" precipitant="M727" effect="M749"/>
<Interaction id="I247" type="Pharmacodynamic interaction" trigger="M750" precipitant="M727" effect="M752"/>
<Interaction id="I248" type="Pharmacodynamic interaction" trigger="M750" precipitant="M733" effect="M749"/>
<Interaction id="I249" type="Pharmacodynamic interaction" trigger="M750" precipitant="M733" effect="M752"/>
<Interaction id="I250" type="Pharmacodynamic interaction" trigger="M750" precipitant="M739" effect="M749"/>
<Interaction id="I251" type="Pharmacodynamic interaction" trigger="M750" precipitant="M739" effect="M752"/>
<Interaction id="I252" type="Pharmacodynamic interaction" trigger="M750" precipitant="M745" effect="M749"/>
<Interaction id="I253" type="Pharmacodynamic interaction" trigger="M750" precipitant="M745" effect="M752"/>
<Interaction id="I254" type="Pharmacodynamic interaction" trigger="M750" precipitant="M751" effect="M749"/>
<Interaction id="I255" type="Pharmacodynamic interaction" trigger="M750" precipitant="M751" effect="M752"/>
</Sentence>
<Sentence id="273" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine .</SentenceText>
<Mention id="M804" type="Trigger" span="318 17" str="lead to increases"/>
<Mention id="M757" type="Precipitant" span="52 46" str="agents that block the renin-angiotensin system" code="n0000175561"/>
<Mention id="M803" type="SpecificInteraction" span="388 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M806" type="SpecificInteraction" span="326 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M763" type="Precipitant" span="169 9" str="amiloride" code="N0000006772"/>
<Mention id="M769" type="Precipitant" span="254 40" str="drugs that may increase potassium levels" code="NO MAP"/>
<Mention id="M775" type="Precipitant" span="304 7" str="heparin" code="N0000006341"/>
<Mention id="M781" type="Precipitant" span="183 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M787" type="Precipitant" span="101 27" str="potassium-sparing diuretics" code="N0000175418"/>
<Mention id="M793" type="Precipitant" span="207 37" str="salt substitutes containing potassium" code="NO MAP"/>
<Mention id="M799" type="Precipitant" span="138 14" str="spironolactone" code="N0000005900"/>
<Mention id="M805" type="Precipitant" span="155 11" str="triamterene" code="N0000005985"/>
<Interaction id="I256" type="Pharmacodynamic interaction" trigger="M804" precipitant="M757" effect="M803"/>
<Interaction id="I257" type="Pharmacodynamic interaction" trigger="M804" precipitant="M757" effect="M806"/>
<Interaction id="I258" type="Pharmacodynamic interaction" trigger="M804" precipitant="M763" effect="M803"/>
<Interaction id="I259" type="Pharmacodynamic interaction" trigger="M804" precipitant="M763" effect="M806"/>
<Interaction id="I260" type="Pharmacodynamic interaction" trigger="M804" precipitant="M769" effect="M803"/>
<Interaction id="I261" type="Pharmacodynamic interaction" trigger="M804" precipitant="M769" effect="M806"/>
<Interaction id="I262" type="Pharmacodynamic interaction" trigger="M804" precipitant="M775" effect="M803"/>
<Interaction id="I263" type="Pharmacodynamic interaction" trigger="M804" precipitant="M775" effect="M806"/>
<Interaction id="I264" type="Pharmacodynamic interaction" trigger="M804" precipitant="M781" effect="M803"/>
<Interaction id="I265" type="Pharmacodynamic interaction" trigger="M804" precipitant="M781" effect="M806"/>
<Interaction id="I266" type="Pharmacodynamic interaction" trigger="M804" precipitant="M787" effect="M803"/>
<Interaction id="I267" type="Pharmacodynamic interaction" trigger="M804" precipitant="M787" effect="M806"/>
<Interaction id="I268" type="Pharmacodynamic interaction" trigger="M804" precipitant="M793" effect="M803"/>
<Interaction id="I269" type="Pharmacodynamic interaction" trigger="M804" precipitant="M793" effect="M806"/>
<Interaction id="I270" type="Pharmacodynamic interaction" trigger="M804" precipitant="M799" effect="M803"/>
<Interaction id="I271" type="Pharmacodynamic interaction" trigger="M804" precipitant="M799" effect="M806"/>
<Interaction id="I272" type="Pharmacodynamic interaction" trigger="M804" precipitant="M805" effect="M803"/>
<Interaction id="I273" type="Pharmacodynamic interaction" trigger="M804" precipitant="M805" effect="M806"/>
</Sentence>
<Sentence id="273" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine .</SentenceText>
<Mention id="M858" type="Trigger" span="318 17" str="lead to increases"/>
<Mention id="M811" type="Precipitant" span="52 46" str="agents that block the renin-angiotensin system" code="n0000175561"/>
<Mention id="M857" type="SpecificInteraction" span="388 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M860" type="SpecificInteraction" span="326 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M817" type="Precipitant" span="169 9" str="amiloride" code="N0000006772"/>
<Mention id="M823" type="Precipitant" span="254 40" str="drugs that may increase potassium levels" code="NO MAP"/>
<Mention id="M829" type="Precipitant" span="304 7" str="heparin" code="N0000006341"/>
<Mention id="M835" type="Precipitant" span="183 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M841" type="Precipitant" span="101 27" str="potassium-sparing diuretics" code="N0000175418"/>
<Mention id="M847" type="Precipitant" span="207 37" str="salt substitutes containing potassium" code="NO MAP"/>
<Mention id="M853" type="Precipitant" span="138 14" str="spironolactone" code="N0000005900"/>
<Mention id="M859" type="Precipitant" span="155 11" str="triamterene" code="N0000005985"/>
<Interaction id="I274" type="Pharmacodynamic interaction" trigger="M858" precipitant="M811" effect="M857"/>
<Interaction id="I275" type="Pharmacodynamic interaction" trigger="M858" precipitant="M811" effect="M860"/>
<Interaction id="I276" type="Pharmacodynamic interaction" trigger="M858" precipitant="M817" effect="M857"/>
<Interaction id="I277" type="Pharmacodynamic interaction" trigger="M858" precipitant="M817" effect="M860"/>
<Interaction id="I278" type="Pharmacodynamic interaction" trigger="M858" precipitant="M823" effect="M857"/>
<Interaction id="I279" type="Pharmacodynamic interaction" trigger="M858" precipitant="M823" effect="M860"/>
<Interaction id="I280" type="Pharmacodynamic interaction" trigger="M858" precipitant="M829" effect="M857"/>
<Interaction id="I281" type="Pharmacodynamic interaction" trigger="M858" precipitant="M829" effect="M860"/>
<Interaction id="I282" type="Pharmacodynamic interaction" trigger="M858" precipitant="M835" effect="M857"/>
<Interaction id="I283" type="Pharmacodynamic interaction" trigger="M858" precipitant="M835" effect="M860"/>
<Interaction id="I284" type="Pharmacodynamic interaction" trigger="M858" precipitant="M841" effect="M857"/>
<Interaction id="I285" type="Pharmacodynamic interaction" trigger="M858" precipitant="M841" effect="M860"/>
<Interaction id="I286" type="Pharmacodynamic interaction" trigger="M858" precipitant="M847" effect="M857"/>
<Interaction id="I287" type="Pharmacodynamic interaction" trigger="M858" precipitant="M847" effect="M860"/>
<Interaction id="I288" type="Pharmacodynamic interaction" trigger="M858" precipitant="M853" effect="M857"/>
<Interaction id="I289" type="Pharmacodynamic interaction" trigger="M858" precipitant="M853" effect="M860"/>
<Interaction id="I290" type="Pharmacodynamic interaction" trigger="M858" precipitant="M859" effect="M857"/>
<Interaction id="I291" type="Pharmacodynamic interaction" trigger="M858" precipitant="M859" effect="M860"/>
</Sentence>
<Sentence id="273" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine .</SentenceText>
<Mention id="M912" type="Trigger" span="318 17" str="lead to increases"/>
<Mention id="M865" type="Precipitant" span="52 46" str="agents that block the renin-angiotensin system" code="n0000175561"/>
<Mention id="M911" type="SpecificInteraction" span="388 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M914" type="SpecificInteraction" span="326 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M871" type="Precipitant" span="169 9" str="amiloride" code="N0000006772"/>
<Mention id="M877" type="Precipitant" span="254 40" str="drugs that may increase potassium levels" code="NO MAP"/>
<Mention id="M883" type="Precipitant" span="304 7" str="heparin" code="N0000006341"/>
<Mention id="M889" type="Precipitant" span="183 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M895" type="Precipitant" span="101 27" str="potassium-sparing diuretics" code="N0000175418"/>
<Mention id="M901" type="Precipitant" span="207 37" str="salt substitutes containing potassium" code="NO MAP"/>
<Mention id="M907" type="Precipitant" span="138 14" str="spironolactone" code="N0000005900"/>
<Mention id="M913" type="Precipitant" span="155 11" str="triamterene" code="N0000005985"/>
<Interaction id="I292" type="Pharmacodynamic interaction" trigger="M912" precipitant="M865" effect="M911"/>
<Interaction id="I293" type="Pharmacodynamic interaction" trigger="M912" precipitant="M865" effect="M914"/>
<Interaction id="I294" type="Pharmacodynamic interaction" trigger="M912" precipitant="M871" effect="M911"/>
<Interaction id="I295" type="Pharmacodynamic interaction" trigger="M912" precipitant="M871" effect="M914"/>
<Interaction id="I296" type="Pharmacodynamic interaction" trigger="M912" precipitant="M877" effect="M911"/>
<Interaction id="I297" type="Pharmacodynamic interaction" trigger="M912" precipitant="M877" effect="M914"/>
<Interaction id="I298" type="Pharmacodynamic interaction" trigger="M912" precipitant="M883" effect="M911"/>
<Interaction id="I299" type="Pharmacodynamic interaction" trigger="M912" precipitant="M883" effect="M914"/>
<Interaction id="I300" type="Pharmacodynamic interaction" trigger="M912" precipitant="M889" effect="M911"/>
<Interaction id="I301" type="Pharmacodynamic interaction" trigger="M912" precipitant="M889" effect="M914"/>
<Interaction id="I302" type="Pharmacodynamic interaction" trigger="M912" precipitant="M895" effect="M911"/>
<Interaction id="I303" type="Pharmacodynamic interaction" trigger="M912" precipitant="M895" effect="M914"/>
<Interaction id="I304" type="Pharmacodynamic interaction" trigger="M912" precipitant="M901" effect="M911"/>
<Interaction id="I305" type="Pharmacodynamic interaction" trigger="M912" precipitant="M901" effect="M914"/>
<Interaction id="I306" type="Pharmacodynamic interaction" trigger="M912" precipitant="M907" effect="M911"/>
<Interaction id="I307" type="Pharmacodynamic interaction" trigger="M912" precipitant="M907" effect="M914"/>
<Interaction id="I308" type="Pharmacodynamic interaction" trigger="M912" precipitant="M913" effect="M911"/>
<Interaction id="I309" type="Pharmacodynamic interaction" trigger="M912" precipitant="M913" effect="M914"/>
</Sentence>
<Sentence id="273" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine .</SentenceText>
<Mention id="M966" type="Trigger" span="318 17" str="lead to increases"/>
<Mention id="M919" type="Precipitant" span="52 46" str="agents that block the renin-angiotensin system" code="n0000175561"/>
<Mention id="M965" type="SpecificInteraction" span="388 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M968" type="SpecificInteraction" span="326 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M925" type="Precipitant" span="169 9" str="amiloride" code="N0000006772"/>
<Mention id="M931" type="Precipitant" span="254 40" str="drugs that may increase potassium levels" code="NO MAP"/>
<Mention id="M937" type="Precipitant" span="304 7" str="heparin" code="N0000006341"/>
<Mention id="M943" type="Precipitant" span="183 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M949" type="Precipitant" span="101 27" str="potassium-sparing diuretics" code="N0000175418"/>
<Mention id="M955" type="Precipitant" span="207 37" str="salt substitutes containing potassium" code="NO MAP"/>
<Mention id="M961" type="Precipitant" span="138 14" str="spironolactone" code="N0000005900"/>
<Mention id="M967" type="Precipitant" span="155 11" str="triamterene" code="N0000005985"/>
<Interaction id="I310" type="Pharmacodynamic interaction" trigger="M966" precipitant="M919" effect="M965"/>
<Interaction id="I311" type="Pharmacodynamic interaction" trigger="M966" precipitant="M919" effect="M968"/>
<Interaction id="I312" type="Pharmacodynamic interaction" trigger="M966" precipitant="M925" effect="M965"/>
<Interaction id="I313" type="Pharmacodynamic interaction" trigger="M966" precipitant="M925" effect="M968"/>
<Interaction id="I314" type="Pharmacodynamic interaction" trigger="M966" precipitant="M931" effect="M965"/>
<Interaction id="I315" type="Pharmacodynamic interaction" trigger="M966" precipitant="M931" effect="M968"/>
<Interaction id="I316" type="Pharmacodynamic interaction" trigger="M966" precipitant="M937" effect="M965"/>
<Interaction id="I317" type="Pharmacodynamic interaction" trigger="M966" precipitant="M937" effect="M968"/>
<Interaction id="I318" type="Pharmacodynamic interaction" trigger="M966" precipitant="M943" effect="M965"/>
<Interaction id="I319" type="Pharmacodynamic interaction" trigger="M966" precipitant="M943" effect="M968"/>
<Interaction id="I320" type="Pharmacodynamic interaction" trigger="M966" precipitant="M949" effect="M965"/>
<Interaction id="I321" type="Pharmacodynamic interaction" trigger="M966" precipitant="M949" effect="M968"/>
<Interaction id="I322" type="Pharmacodynamic interaction" trigger="M966" precipitant="M955" effect="M965"/>
<Interaction id="I323" type="Pharmacodynamic interaction" trigger="M966" precipitant="M955" effect="M968"/>
<Interaction id="I324" type="Pharmacodynamic interaction" trigger="M966" precipitant="M961" effect="M965"/>
<Interaction id="I325" type="Pharmacodynamic interaction" trigger="M966" precipitant="M961" effect="M968"/>
<Interaction id="I326" type="Pharmacodynamic interaction" trigger="M966" precipitant="M967" effect="M965"/>
<Interaction id="I327" type="Pharmacodynamic interaction" trigger="M966" precipitant="M967" effect="M968"/>
</Sentence>
<Sentence id="273" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine .</SentenceText>
<Mention id="M1020" type="Trigger" span="318 17" str="lead to increases"/>
<Mention id="M973" type="Precipitant" span="52 46" str="agents that block the renin-angiotensin system" code="n0000175561"/>
<Mention id="M1019" type="SpecificInteraction" span="388 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M1022" type="SpecificInteraction" span="326 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M979" type="Precipitant" span="169 9" str="amiloride" code="N0000006772"/>
<Mention id="M985" type="Precipitant" span="254 40" str="drugs that may increase potassium levels" code="NO MAP"/>
<Mention id="M991" type="Precipitant" span="304 7" str="heparin" code="N0000006341"/>
<Mention id="M997" type="Precipitant" span="183 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M1003" type="Precipitant" span="101 27" str="potassium-sparing diuretics" code="N0000175418"/>
<Mention id="M1009" type="Precipitant" span="207 37" str="salt substitutes containing potassium" code="NO MAP"/>
<Mention id="M1015" type="Precipitant" span="138 14" str="spironolactone" code="N0000005900"/>
<Mention id="M1021" type="Precipitant" span="155 11" str="triamterene" code="N0000005985"/>
<Interaction id="I328" type="Pharmacodynamic interaction" trigger="M1020" precipitant="M973" effect="M1019"/>
<Interaction id="I329" type="Pharmacodynamic interaction" trigger="M1020" precipitant="M973" effect="M1022"/>
<Interaction id="I330" type="Pharmacodynamic interaction" trigger="M1020" precipitant="M979" effect="M1019"/>
<Interaction id="I331" type="Pharmacodynamic interaction" trigger="M1020" precipitant="M979" effect="M1022"/>
<Interaction id="I332" type="Pharmacodynamic interaction" trigger="M1020" precipitant="M985" effect="M1019"/>
<Interaction id="I333" type="Pharmacodynamic interaction" trigger="M1020" precipitant="M985" effect="M1022"/>
<Interaction id="I334" type="Pharmacodynamic interaction" trigger="M1020" precipitant="M991" effect="M1019"/>
<Interaction id="I335" type="Pharmacodynamic interaction" trigger="M1020" precipitant="M991" effect="M1022"/>
<Interaction id="I336" type="Pharmacodynamic interaction" trigger="M1020" precipitant="M997" effect="M1019"/>
<Interaction id="I337" type="Pharmacodynamic interaction" trigger="M1020" precipitant="M997" effect="M1022"/>
<Interaction id="I338" type="Pharmacodynamic interaction" trigger="M1020" precipitant="M1003" effect="M1019"/>
<Interaction id="I339" type="Pharmacodynamic interaction" trigger="M1020" precipitant="M1003" effect="M1022"/>
<Interaction id="I340" type="Pharmacodynamic interaction" trigger="M1020" precipitant="M1009" effect="M1019"/>
<Interaction id="I341" type="Pharmacodynamic interaction" trigger="M1020" precipitant="M1009" effect="M1022"/>
<Interaction id="I342" type="Pharmacodynamic interaction" trigger="M1020" precipitant="M1015" effect="M1019"/>
<Interaction id="I343" type="Pharmacodynamic interaction" trigger="M1020" precipitant="M1015" effect="M1022"/>
<Interaction id="I344" type="Pharmacodynamic interaction" trigger="M1020" precipitant="M1021" effect="M1019"/>
<Interaction id="I345" type="Pharmacodynamic interaction" trigger="M1020" precipitant="M1021" effect="M1022"/>
</Sentence>
<Sentence id="273" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine .</SentenceText>
<Mention id="M1074" type="Trigger" span="318 17" str="lead to increases"/>
<Mention id="M1027" type="Precipitant" span="52 46" str="agents that block the renin-angiotensin system" code="n0000175561"/>
<Mention id="M1073" type="SpecificInteraction" span="388 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M1076" type="SpecificInteraction" span="326 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M1033" type="Precipitant" span="169 9" str="amiloride" code="N0000006772"/>
<Mention id="M1039" type="Precipitant" span="254 40" str="drugs that may increase potassium levels" code="NO MAP"/>
<Mention id="M1045" type="Precipitant" span="304 7" str="heparin" code="N0000006341"/>
<Mention id="M1051" type="Precipitant" span="183 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M1057" type="Precipitant" span="101 27" str="potassium-sparing diuretics" code="N0000175418"/>
<Mention id="M1063" type="Precipitant" span="207 37" str="salt substitutes containing potassium" code="NO MAP"/>
<Mention id="M1069" type="Precipitant" span="138 14" str="spironolactone" code="N0000005900"/>
<Mention id="M1075" type="Precipitant" span="155 11" str="triamterene" code="N0000005985"/>
<Interaction id="I346" type="Pharmacodynamic interaction" trigger="M1074" precipitant="M1027" effect="M1073"/>
<Interaction id="I347" type="Pharmacodynamic interaction" trigger="M1074" precipitant="M1027" effect="M1076"/>
<Interaction id="I348" type="Pharmacodynamic interaction" trigger="M1074" precipitant="M1033" effect="M1073"/>
<Interaction id="I349" type="Pharmacodynamic interaction" trigger="M1074" precipitant="M1033" effect="M1076"/>
<Interaction id="I350" type="Pharmacodynamic interaction" trigger="M1074" precipitant="M1039" effect="M1073"/>
<Interaction id="I351" type="Pharmacodynamic interaction" trigger="M1074" precipitant="M1039" effect="M1076"/>
<Interaction id="I352" type="Pharmacodynamic interaction" trigger="M1074" precipitant="M1045" effect="M1073"/>
<Interaction id="I353" type="Pharmacodynamic interaction" trigger="M1074" precipitant="M1045" effect="M1076"/>
<Interaction id="I354" type="Pharmacodynamic interaction" trigger="M1074" precipitant="M1051" effect="M1073"/>
<Interaction id="I355" type="Pharmacodynamic interaction" trigger="M1074" precipitant="M1051" effect="M1076"/>
<Interaction id="I356" type="Pharmacodynamic interaction" trigger="M1074" precipitant="M1057" effect="M1073"/>
<Interaction id="I357" type="Pharmacodynamic interaction" trigger="M1074" precipitant="M1057" effect="M1076"/>
<Interaction id="I358" type="Pharmacodynamic interaction" trigger="M1074" precipitant="M1063" effect="M1073"/>
<Interaction id="I359" type="Pharmacodynamic interaction" trigger="M1074" precipitant="M1063" effect="M1076"/>
<Interaction id="I360" type="Pharmacodynamic interaction" trigger="M1074" precipitant="M1069" effect="M1073"/>
<Interaction id="I361" type="Pharmacodynamic interaction" trigger="M1074" precipitant="M1069" effect="M1076"/>
<Interaction id="I362" type="Pharmacodynamic interaction" trigger="M1074" precipitant="M1075" effect="M1073"/>
<Interaction id="I363" type="Pharmacodynamic interaction" trigger="M1074" precipitant="M1075" effect="M1076"/>
</Sentence>
<Sentence id="273" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine .</SentenceText>
<Mention id="M1128" type="Trigger" span="318 17" str="lead to increases"/>
<Mention id="M1081" type="Precipitant" span="52 46" str="agents that block the renin-angiotensin system" code="n0000175561"/>
<Mention id="M1127" type="SpecificInteraction" span="388 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M1130" type="SpecificInteraction" span="326 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M1087" type="Precipitant" span="169 9" str="amiloride" code="N0000006772"/>
<Mention id="M1093" type="Precipitant" span="254 40" str="drugs that may increase potassium levels" code="NO MAP"/>
<Mention id="M1099" type="Precipitant" span="304 7" str="heparin" code="N0000006341"/>
<Mention id="M1105" type="Precipitant" span="183 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M1111" type="Precipitant" span="101 27" str="potassium-sparing diuretics" code="N0000175418"/>
<Mention id="M1117" type="Precipitant" span="207 37" str="salt substitutes containing potassium" code="NO MAP"/>
<Mention id="M1123" type="Precipitant" span="138 14" str="spironolactone" code="N0000005900"/>
<Mention id="M1129" type="Precipitant" span="155 11" str="triamterene" code="N0000005985"/>
<Interaction id="I364" type="Pharmacodynamic interaction" trigger="M1128" precipitant="M1081" effect="M1127"/>
<Interaction id="I365" type="Pharmacodynamic interaction" trigger="M1128" precipitant="M1081" effect="M1130"/>
<Interaction id="I366" type="Pharmacodynamic interaction" trigger="M1128" precipitant="M1087" effect="M1127"/>
<Interaction id="I367" type="Pharmacodynamic interaction" trigger="M1128" precipitant="M1087" effect="M1130"/>
<Interaction id="I368" type="Pharmacodynamic interaction" trigger="M1128" precipitant="M1093" effect="M1127"/>
<Interaction id="I369" type="Pharmacodynamic interaction" trigger="M1128" precipitant="M1093" effect="M1130"/>
<Interaction id="I370" type="Pharmacodynamic interaction" trigger="M1128" precipitant="M1099" effect="M1127"/>
<Interaction id="I371" type="Pharmacodynamic interaction" trigger="M1128" precipitant="M1099" effect="M1130"/>
<Interaction id="I372" type="Pharmacodynamic interaction" trigger="M1128" precipitant="M1105" effect="M1127"/>
<Interaction id="I373" type="Pharmacodynamic interaction" trigger="M1128" precipitant="M1105" effect="M1130"/>
<Interaction id="I374" type="Pharmacodynamic interaction" trigger="M1128" precipitant="M1111" effect="M1127"/>
<Interaction id="I375" type="Pharmacodynamic interaction" trigger="M1128" precipitant="M1111" effect="M1130"/>
<Interaction id="I376" type="Pharmacodynamic interaction" trigger="M1128" precipitant="M1117" effect="M1127"/>
<Interaction id="I377" type="Pharmacodynamic interaction" trigger="M1128" precipitant="M1117" effect="M1130"/>
<Interaction id="I378" type="Pharmacodynamic interaction" trigger="M1128" precipitant="M1123" effect="M1127"/>
<Interaction id="I379" type="Pharmacodynamic interaction" trigger="M1128" precipitant="M1123" effect="M1130"/>
<Interaction id="I380" type="Pharmacodynamic interaction" trigger="M1128" precipitant="M1129" effect="M1127"/>
<Interaction id="I381" type="Pharmacodynamic interaction" trigger="M1128" precipitant="M1129" effect="M1130"/>
</Sentence>
<Sentence id="274" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium-sparing diuretics, potassium supplements or salt substitutes may lead to increases in serum potassium, and in heart failure patients, increases in serum creatinine (7) NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect (7) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7) Lithium: Increases in serum lithium concentrations and lithium toxicity (7) In controlled clinical trials, clinically important changes in standard laboratory parameters were rarely associated with administration of Diovan.</SentenceText>
<Mention id="M1131" type="Trigger" span="403 18;430 14" str="Increases in serum | concentrations"/>
<Mention id="M1132" type="Precipitant" span="422 7" str="lithium" code="N0000147892"/>
<Mention id="M1133" type="Trigger" span="200 14" str="increased risk"/>
<Mention id="M1134" type="Precipitant" span="178 5" str="NSAID" code="N0000175722"/>
<Mention id="M1135" type="SpecificInteraction" span="218 16" str="renal impairment " code="236423003: Renal impairment (disorder)"/>
<Mention id="M1136" type="SpecificInteraction" span="239 31" str=" loss of antihypertensive effect" code=""/>
<Mention id="M1152" type="Trigger" span="75 17" str="lead to increases"/>
<Mention id="M1141" type="Precipitant" span="29 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M1151" type="SpecificInteraction" span="144 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M1154" type="SpecificInteraction" span="83 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M1147" type="Precipitant" span="0 27" str="Potassium-sparing diuretics" code="n0000175418"/>
<Mention id="M1153" type="Precipitant" span="54 16" str="salt substitutes" code="N0000007207"/>
<Interaction id="I382" type="Pharmacokinetic interaction" trigger="M1131" precipitant="M1132" effect="C54357"/>
<Interaction id="I383" type="Pharmacodynamic interaction" trigger="M1133" precipitant="M1134" effect="M1135;M1136"/>
<Interaction id="I384" type="Pharmacodynamic interaction" trigger="M1152" precipitant="M1141" effect="M1151"/>
<Interaction id="I385" type="Pharmacodynamic interaction" trigger="M1152" precipitant="M1141" effect="M1154"/>
<Interaction id="I386" type="Pharmacodynamic interaction" trigger="M1152" precipitant="M1147" effect="M1151"/>
<Interaction id="I387" type="Pharmacodynamic interaction" trigger="M1152" precipitant="M1147" effect="M1154"/>
<Interaction id="I388" type="Pharmacodynamic interaction" trigger="M1152" precipitant="M1153" effect="M1151"/>
<Interaction id="I389" type="Pharmacodynamic interaction" trigger="M1152" precipitant="M1153" effect="M1154"/>
</Sentence>
<Sentence id="274" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium-sparing diuretics, potassium supplements or salt substitutes may lead to increases in serum potassium, and in heart failure patients, increases in serum creatinine (7) NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect (7) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7) Lithium: Increases in serum lithium concentrations and lithium toxicity (7) In controlled clinical trials, clinically important changes in standard laboratory parameters were rarely associated with administration of Diovan.</SentenceText>
<Mention id="M1155" type="Trigger" span="403 18;430 14" str="Increases in serum | concentrations"/>
<Mention id="M1156" type="Precipitant" span="422 7" str="lithium" code="N0000147892"/>
<Mention id="M1157" type="Trigger" span="200 14" str="increased risk"/>
<Mention id="M1158" type="Precipitant" span="178 5" str="NSAID" code="N0000175722"/>
<Mention id="M1159" type="SpecificInteraction" span="218 16" str="renal impairment " code="236423003: Renal impairment (disorder)"/>
<Mention id="M1160" type="SpecificInteraction" span="239 31" str=" loss of antihypertensive effect" code=""/>
<Mention id="M1176" type="Trigger" span="75 17" str="lead to increases"/>
<Mention id="M1165" type="Precipitant" span="29 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M1175" type="SpecificInteraction" span="144 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M1178" type="SpecificInteraction" span="83 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M1171" type="Precipitant" span="0 27" str="Potassium-sparing diuretics" code="n0000175418"/>
<Mention id="M1177" type="Precipitant" span="54 16" str="salt substitutes" code="N0000007207"/>
<Interaction id="I390" type="Pharmacokinetic interaction" trigger="M1155" precipitant="M1156" effect="C54357"/>
<Interaction id="I391" type="Pharmacodynamic interaction" trigger="M1157" precipitant="M1158" effect="M1159;M1160"/>
<Interaction id="I392" type="Pharmacodynamic interaction" trigger="M1176" precipitant="M1165" effect="M1175"/>
<Interaction id="I393" type="Pharmacodynamic interaction" trigger="M1176" precipitant="M1165" effect="M1178"/>
<Interaction id="I394" type="Pharmacodynamic interaction" trigger="M1176" precipitant="M1171" effect="M1175"/>
<Interaction id="I395" type="Pharmacodynamic interaction" trigger="M1176" precipitant="M1171" effect="M1178"/>
<Interaction id="I396" type="Pharmacodynamic interaction" trigger="M1176" precipitant="M1177" effect="M1175"/>
<Interaction id="I397" type="Pharmacodynamic interaction" trigger="M1176" precipitant="M1177" effect="M1178"/>
</Sentence>
<Sentence id="274" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium-sparing diuretics, potassium supplements or salt substitutes may lead to increases in serum potassium, and in heart failure patients, increases in serum creatinine (7) NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect (7) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7) Lithium: Increases in serum lithium concentrations and lithium toxicity (7) In controlled clinical trials, clinically important changes in standard laboratory parameters were rarely associated with administration of Diovan.</SentenceText>
<Mention id="M1179" type="Trigger" span="403 18;430 14" str="Increases in serum | concentrations"/>
<Mention id="M1180" type="Precipitant" span="422 7" str="lithium" code="N0000147892"/>
<Mention id="M1181" type="Trigger" span="200 14" str="increased risk"/>
<Mention id="M1182" type="Precipitant" span="178 5" str="NSAID" code="N0000175722"/>
<Mention id="M1183" type="SpecificInteraction" span="218 16" str="renal impairment " code="236423003: Renal impairment (disorder)"/>
<Mention id="M1184" type="SpecificInteraction" span="239 31" str=" loss of antihypertensive effect" code=""/>
<Mention id="M1200" type="Trigger" span="75 17" str="lead to increases"/>
<Mention id="M1189" type="Precipitant" span="29 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M1199" type="SpecificInteraction" span="144 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M1202" type="SpecificInteraction" span="83 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M1195" type="Precipitant" span="0 27" str="Potassium-sparing diuretics" code="n0000175418"/>
<Mention id="M1201" type="Precipitant" span="54 16" str="salt substitutes" code="N0000007207"/>
<Interaction id="I398" type="Pharmacokinetic interaction" trigger="M1179" precipitant="M1180" effect="C54357"/>
<Interaction id="I399" type="Pharmacodynamic interaction" trigger="M1181" precipitant="M1182" effect="M1183;M1184"/>
<Interaction id="I400" type="Pharmacodynamic interaction" trigger="M1200" precipitant="M1189" effect="M1199"/>
<Interaction id="I401" type="Pharmacodynamic interaction" trigger="M1200" precipitant="M1189" effect="M1202"/>
<Interaction id="I402" type="Pharmacodynamic interaction" trigger="M1200" precipitant="M1195" effect="M1199"/>
<Interaction id="I403" type="Pharmacodynamic interaction" trigger="M1200" precipitant="M1195" effect="M1202"/>
<Interaction id="I404" type="Pharmacodynamic interaction" trigger="M1200" precipitant="M1201" effect="M1199"/>
<Interaction id="I405" type="Pharmacodynamic interaction" trigger="M1200" precipitant="M1201" effect="M1202"/>
</Sentence>
<Sentence id="274" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium-sparing diuretics, potassium supplements or salt substitutes may lead to increases in serum potassium, and in heart failure patients, increases in serum creatinine (7) NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect (7) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7) Lithium: Increases in serum lithium concentrations and lithium toxicity (7) In controlled clinical trials, clinically important changes in standard laboratory parameters were rarely associated with administration of Diovan.</SentenceText>
<Mention id="M1203" type="Trigger" span="403 18;430 14" str="Increases in serum | concentrations"/>
<Mention id="M1204" type="Precipitant" span="422 7" str="lithium" code="N0000147892"/>
<Mention id="M1205" type="Trigger" span="200 14" str="increased risk"/>
<Mention id="M1206" type="Precipitant" span="178 5" str="NSAID" code="N0000175722"/>
<Mention id="M1207" type="SpecificInteraction" span="218 16" str="renal impairment " code="236423003: Renal impairment (disorder)"/>
<Mention id="M1208" type="SpecificInteraction" span="239 31" str=" loss of antihypertensive effect" code=""/>
<Mention id="M1224" type="Trigger" span="75 17" str="lead to increases"/>
<Mention id="M1213" type="Precipitant" span="29 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M1223" type="SpecificInteraction" span="144 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M1226" type="SpecificInteraction" span="83 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M1219" type="Precipitant" span="0 27" str="Potassium-sparing diuretics" code="n0000175418"/>
<Mention id="M1225" type="Precipitant" span="54 16" str="salt substitutes" code="N0000007207"/>
<Interaction id="I406" type="Pharmacokinetic interaction" trigger="M1203" precipitant="M1204" effect="C54357"/>
<Interaction id="I407" type="Pharmacodynamic interaction" trigger="M1205" precipitant="M1206" effect="M1207;M1208"/>
<Interaction id="I408" type="Pharmacodynamic interaction" trigger="M1224" precipitant="M1213" effect="M1223"/>
<Interaction id="I409" type="Pharmacodynamic interaction" trigger="M1224" precipitant="M1213" effect="M1226"/>
<Interaction id="I410" type="Pharmacodynamic interaction" trigger="M1224" precipitant="M1219" effect="M1223"/>
<Interaction id="I411" type="Pharmacodynamic interaction" trigger="M1224" precipitant="M1219" effect="M1226"/>
<Interaction id="I412" type="Pharmacodynamic interaction" trigger="M1224" precipitant="M1225" effect="M1223"/>
<Interaction id="I413" type="Pharmacodynamic interaction" trigger="M1224" precipitant="M1225" effect="M1226"/>
</Sentence>
<Sentence id="274" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium-sparing diuretics, potassium supplements or salt substitutes may lead to increases in serum potassium, and in heart failure patients, increases in serum creatinine (7) NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect (7) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7) Lithium: Increases in serum lithium concentrations and lithium toxicity (7) In controlled clinical trials, clinically important changes in standard laboratory parameters were rarely associated with administration of Diovan.</SentenceText>
<Mention id="M1227" type="Trigger" span="403 18;430 14" str="Increases in serum | concentrations"/>
<Mention id="M1228" type="Precipitant" span="422 7" str="lithium" code="N0000147892"/>
<Mention id="M1229" type="Trigger" span="200 14" str="increased risk"/>
<Mention id="M1230" type="Precipitant" span="178 5" str="NSAID" code="N0000175722"/>
<Mention id="M1231" type="SpecificInteraction" span="218 16" str="renal impairment " code="236423003: Renal impairment (disorder)"/>
<Mention id="M1232" type="SpecificInteraction" span="239 31" str=" loss of antihypertensive effect" code=""/>
<Mention id="M1248" type="Trigger" span="75 17" str="lead to increases"/>
<Mention id="M1237" type="Precipitant" span="29 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M1247" type="SpecificInteraction" span="144 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M1250" type="SpecificInteraction" span="83 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M1243" type="Precipitant" span="0 27" str="Potassium-sparing diuretics" code="n0000175418"/>
<Mention id="M1249" type="Precipitant" span="54 16" str="salt substitutes" code="N0000007207"/>
<Interaction id="I414" type="Pharmacokinetic interaction" trigger="M1227" precipitant="M1228" effect="C54357"/>
<Interaction id="I415" type="Pharmacodynamic interaction" trigger="M1229" precipitant="M1230" effect="M1231;M1232"/>
<Interaction id="I416" type="Pharmacodynamic interaction" trigger="M1248" precipitant="M1237" effect="M1247"/>
<Interaction id="I417" type="Pharmacodynamic interaction" trigger="M1248" precipitant="M1237" effect="M1250"/>
<Interaction id="I418" type="Pharmacodynamic interaction" trigger="M1248" precipitant="M1243" effect="M1247"/>
<Interaction id="I419" type="Pharmacodynamic interaction" trigger="M1248" precipitant="M1243" effect="M1250"/>
<Interaction id="I420" type="Pharmacodynamic interaction" trigger="M1248" precipitant="M1249" effect="M1247"/>
<Interaction id="I421" type="Pharmacodynamic interaction" trigger="M1248" precipitant="M1249" effect="M1250"/>
</Sentence>
<Sentence id="274" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium-sparing diuretics, potassium supplements or salt substitutes may lead to increases in serum potassium, and in heart failure patients, increases in serum creatinine (7) NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect (7) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7) Lithium: Increases in serum lithium concentrations and lithium toxicity (7) In controlled clinical trials, clinically important changes in standard laboratory parameters were rarely associated with administration of Diovan.</SentenceText>
<Mention id="M1251" type="Trigger" span="403 18;430 14" str="Increases in serum | concentrations"/>
<Mention id="M1252" type="Precipitant" span="422 7" str="lithium" code="N0000147892"/>
<Mention id="M1253" type="Trigger" span="200 14" str="increased risk"/>
<Mention id="M1254" type="Precipitant" span="178 5" str="NSAID" code="N0000175722"/>
<Mention id="M1255" type="SpecificInteraction" span="218 16" str="renal impairment " code="236423003: Renal impairment (disorder)"/>
<Mention id="M1256" type="SpecificInteraction" span="239 31" str=" loss of antihypertensive effect" code=""/>
<Mention id="M1272" type="Trigger" span="75 17" str="lead to increases"/>
<Mention id="M1261" type="Precipitant" span="29 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M1271" type="SpecificInteraction" span="144 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M1274" type="SpecificInteraction" span="83 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M1267" type="Precipitant" span="0 27" str="Potassium-sparing diuretics" code="n0000175418"/>
<Mention id="M1273" type="Precipitant" span="54 16" str="salt substitutes" code="N0000007207"/>
<Interaction id="I422" type="Pharmacokinetic interaction" trigger="M1251" precipitant="M1252" effect="C54357"/>
<Interaction id="I423" type="Pharmacodynamic interaction" trigger="M1253" precipitant="M1254" effect="M1255;M1256"/>
<Interaction id="I424" type="Pharmacodynamic interaction" trigger="M1272" precipitant="M1261" effect="M1271"/>
<Interaction id="I425" type="Pharmacodynamic interaction" trigger="M1272" precipitant="M1261" effect="M1274"/>
<Interaction id="I426" type="Pharmacodynamic interaction" trigger="M1272" precipitant="M1267" effect="M1271"/>
<Interaction id="I427" type="Pharmacodynamic interaction" trigger="M1272" precipitant="M1267" effect="M1274"/>
<Interaction id="I428" type="Pharmacodynamic interaction" trigger="M1272" precipitant="M1273" effect="M1271"/>
<Interaction id="I429" type="Pharmacodynamic interaction" trigger="M1272" precipitant="M1273" effect="M1274"/>
</Sentence>
<Sentence id="274" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium-sparing diuretics, potassium supplements or salt substitutes may lead to increases in serum potassium, and in heart failure patients, increases in serum creatinine (7) NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect (7) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7) Lithium: Increases in serum lithium concentrations and lithium toxicity (7) In controlled clinical trials, clinically important changes in standard laboratory parameters were rarely associated with administration of Diovan.</SentenceText>
<Mention id="M1275" type="Trigger" span="403 18;430 14" str="Increases in serum | concentrations"/>
<Mention id="M1276" type="Precipitant" span="422 7" str="lithium" code="N0000147892"/>
<Mention id="M1277" type="Trigger" span="200 14" str="increased risk"/>
<Mention id="M1278" type="Precipitant" span="178 5" str="NSAID" code="N0000175722"/>
<Mention id="M1279" type="SpecificInteraction" span="218 16" str="renal impairment " code="236423003: Renal impairment (disorder)"/>
<Mention id="M1280" type="SpecificInteraction" span="239 31" str=" loss of antihypertensive effect" code=""/>
<Mention id="M1296" type="Trigger" span="75 17" str="lead to increases"/>
<Mention id="M1285" type="Precipitant" span="29 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M1295" type="SpecificInteraction" span="144 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M1298" type="SpecificInteraction" span="83 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M1291" type="Precipitant" span="0 27" str="Potassium-sparing diuretics" code="n0000175418"/>
<Mention id="M1297" type="Precipitant" span="54 16" str="salt substitutes" code="N0000007207"/>
<Interaction id="I430" type="Pharmacokinetic interaction" trigger="M1275" precipitant="M1276" effect="C54357"/>
<Interaction id="I431" type="Pharmacodynamic interaction" trigger="M1277" precipitant="M1278" effect="M1279;M1280"/>
<Interaction id="I432" type="Pharmacodynamic interaction" trigger="M1296" precipitant="M1285" effect="M1295"/>
<Interaction id="I433" type="Pharmacodynamic interaction" trigger="M1296" precipitant="M1285" effect="M1298"/>
<Interaction id="I434" type="Pharmacodynamic interaction" trigger="M1296" precipitant="M1291" effect="M1295"/>
<Interaction id="I435" type="Pharmacodynamic interaction" trigger="M1296" precipitant="M1291" effect="M1298"/>
<Interaction id="I436" type="Pharmacodynamic interaction" trigger="M1296" precipitant="M1297" effect="M1295"/>
<Interaction id="I437" type="Pharmacodynamic interaction" trigger="M1296" precipitant="M1297" effect="M1298"/>
</Sentence>
<Sentence id="274" LabelDrug="Diovan" section="34073-7">
<SentenceText>Potassium-sparing diuretics, potassium supplements or salt substitutes may lead to increases in serum potassium, and in heart failure patients, increases in serum creatinine (7) NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect (7) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7) Lithium: Increases in serum lithium concentrations and lithium toxicity (7) In controlled clinical trials, clinically important changes in standard laboratory parameters were rarely associated with administration of Diovan.</SentenceText>
<Mention id="M1299" type="Trigger" span="403 18;430 14" str="Increases in serum | concentrations"/>
<Mention id="M1300" type="Precipitant" span="422 7" str="lithium" code="N0000147892"/>
<Mention id="M1301" type="Trigger" span="200 14" str="increased risk"/>
<Mention id="M1302" type="Precipitant" span="178 5" str="NSAID" code="N0000175722"/>
<Mention id="M1303" type="SpecificInteraction" span="218 16" str="renal impairment " code="236423003: Renal impairment (disorder)"/>
<Mention id="M1304" type="SpecificInteraction" span="239 31" str=" loss of antihypertensive effect" code=""/>
<Mention id="M1320" type="Trigger" span="75 17" str="lead to increases"/>
<Mention id="M1309" type="Precipitant" span="29 21" str="potassium supplements" code="N0000175600"/>
<Mention id="M1319" type="SpecificInteraction" span="144 29" str="increases in serum creatinine" code="166717003: Serum creatinine raised (finding)"/>
<Mention id="M1322" type="SpecificInteraction" span="83 28" str="increases in serum potassium" code="166689004: Raised serum potassium level (finding)"/>
<Mention id="M1315" type="Precipitant" span="0 27" str="Potassium-sparing diuretics" code="n0000175418"/>
<Mention id="M1321" type="Precipitant" span="54 16" str="salt substitutes" code="N0000007207"/>
<Interaction id="I438" type="Pharmacokinetic interaction" trigger="M1299" precipitant="M1300" effect="C54357"/>
<Interaction id="I439" type="Pharmacodynamic interaction" trigger="M1301" precipitant="M1302" effect="M1303;M1304"/>
<Interaction id="I440" type="Pharmacodynamic interaction" trigger="M1320" precipitant="M1309" effect="M1319"/>
<Interaction id="I441" type="Pharmacodynamic interaction" trigger="M1320" precipitant="M1309" effect="M1322"/>
<Interaction id="I442" type="Pharmacodynamic interaction" trigger="M1320" precipitant="M1315" effect="M1319"/>
<Interaction id="I443" type="Pharmacodynamic interaction" trigger="M1320" precipitant="M1315" effect="M1322"/>
<Interaction id="I444" type="Pharmacodynamic interaction" trigger="M1320" precipitant="M1321" effect="M1319"/>
<Interaction id="I445" type="Pharmacodynamic interaction" trigger="M1320" precipitant="M1321" effect="M1322"/>
</Sentence>
<Sentence id="275" LabelDrug="Diovan" section="34073-7">
<SentenceText>Serum Potassium: In hypertensive patients, greater than 20% increases in serum potassium were observed in 4.4% of Diovan-treated patients compared to 2.9% of placebo-treated patients.</SentenceText>
</Sentence>
<Sentence id="276" LabelDrug="Diovan" section="34073-7">
<SentenceText>The antihypertensive effect of angiotensin II receptor antagonists , including valsartan , may be attenuated by NSAIDs including selective COX-2 inhibitors .</SentenceText>
<Mention id="M1326" type="Trigger" span="98 10" str="attenuated"/>
<Mention id="M1324" type="Precipitant" span="112 6" str="NSAIDs" code="N0000175722"/>
<Mention id="M1328" type="SpecificInteraction" span="4 23;98 10" str="antihypertensive effect | attenuated" code="NO MAP"/>
<Mention id="M1327" type="Precipitant" span="129 26" str="selective COX-2 inhibitors" code="n0000008288"/>
<Interaction id="I446" type="Pharmacodynamic interaction" trigger="M1326" precipitant="M1324" effect="M1328"/>
<Interaction id="I447" type="Pharmacodynamic interaction" trigger="M1326" precipitant="M1327" effect="M1328"/>
</Sentence>
<Sentence id="276" LabelDrug="Diovan" section="34073-7">
<SentenceText>The antihypertensive effect of angiotensin II receptor antagonists , including valsartan , may be attenuated by NSAIDs including selective COX-2 inhibitors .</SentenceText>
<Mention id="M1332" type="Trigger" span="98 10" str="attenuated"/>
<Mention id="M1330" type="Precipitant" span="112 6" str="NSAIDs" code="N0000175722"/>
<Mention id="M1334" type="SpecificInteraction" span="4 23;98 10" str="antihypertensive effect | attenuated" code="NO MAP"/>
<Mention id="M1333" type="Precipitant" span="129 26" str="selective COX-2 inhibitors" code="n0000008288"/>
<Interaction id="I448" type="Pharmacodynamic interaction" trigger="M1332" precipitant="M1330" effect="M1334"/>
<Interaction id="I449" type="Pharmacodynamic interaction" trigger="M1332" precipitant="M1333" effect="M1334"/>
</Sentence>
<Sentence id="277" LabelDrug="Diovan" section="34073-7">
<SentenceText>The valsartan-atenolol combination was more antihypertensive than either component , but it did not lower the heart rate more than atenolol alone .</SentenceText>
</Sentence>
<Sentence id="278" LabelDrug="Diovan" section="34073-7">
<SentenceText>Three patients (&lt;0.1%) treated with valsartan discontinued treatment for elevated liver chemistries.</SentenceText>
</Sentence>
<Sentence id="279" LabelDrug="Diovan" section="34073-7">
<SentenceText>Transporters: The results from an in vitro study with human liver tissue indicate that valsartan is a substrate of the hepatic uptake transporter OATP1B1 and the hepatic efflux transporter MRP2.</SentenceText>
</Sentence>
<Sentence id="280" LabelDrug="Diovan" section="43685-7">
<SentenceText>In the VALsartan In Acute myocardial iNfarcTion trial ( VALIANT ) , hypotension in post-myocardial infarction patients led to permanent discontinuation of therapy in 1.4 % of valsartan-treated patients and 0.8 % of captopril-treated patients .</SentenceText>
</Sentence>
</Sentences>
<LabelInteractions><LabelInteraction type="Pharmacodynamic interaction" precipitant="aliskiren" precipitantCode="N0000176084" effect=" 14140009: Hyperkalemia (disorder)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="aliskiren" precipitantCode="N0000176084" effect=" 39539005: Abnormal renal function (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="aliskiren" precipitantCode="N0000176084" effect="45007003: Low blood pressure (disorder)"/>
<LabelInteraction type="Unspecified interaction" precipitant="aliskiren" precipitantCode="N0000176084"/>
<LabelInteraction type="Unspecified interaction" precipitant="agents that affect the ras" precipitantCode="NO MAP"/>
<LabelInteraction type="Pharmacokinetic interaction" precipitant="cyclosporine" precipitantCode="N0000007346" effect="C54355"/>
<LabelInteraction type="Pharmacokinetic interaction" precipitant="inhibitors | efflux transporter" precipitantCode="NO MAP" effect="C54355"/>
<LabelInteraction type="Pharmacokinetic interaction" precipitant="inhibitors of the uptake transporter" precipitantCode="NO MAP" effect="C54355"/>
<LabelInteraction type="Pharmacokinetic interaction" precipitant="rifampin" precipitantCode="N0000006026" effect="C54355"/>
<LabelInteraction type="Pharmacokinetic interaction" precipitant="ritonavir" precipitantCode="N0000007423" effect="C54355"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="ace inhibitors" precipitantCode="N0000029130" effect=" 14140009: Hyperkalemia (disorder)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="ace inhibitors" precipitantCode="N0000029130" effect=" 39539005: Abnormal renal function (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="ace inhibitors" precipitantCode="N0000029130" effect="45007003: Low blood pressure (disorder)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="angiotensin receptor blockers" precipitantCode="N0000000070" effect=" 14140009: Hyperkalemia (disorder)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="angiotensin receptor blockers" precipitantCode="N0000000070" effect=" 39539005: Abnormal renal function (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="angiotensin receptor blockers" precipitantCode="N0000000070" effect="45007003: Low blood pressure (disorder)"/>
<LabelInteraction type="Unspecified interaction" precipitant="ras inhibitors" precipitantCode="NO MAP"/>
<LabelInteraction type="Pharmacokinetic interaction" precipitant="lithium" precipitantCode="N0000147892" effect="C54357"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="nsaid" precipitantCode="N0000175722" effect="236423003: Renal impairment (disorder)"/>
<LabelInteraction type="Unspecified interaction" precipitant="nsaid" precipitantCode="N0000175722"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="cox-2 inhibitors" precipitantCode="N0000008288" effect="14669001: Acute renal failure syndrome (disorder)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="cox-2 inhibitors" precipitantCode="N0000008288" effect="314983004: Deteriorating renal function (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="nsaids" precipitantCode="N0000175722" effect="14669001: Acute renal failure syndrome (disorder)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="nsaids" precipitantCode="N0000175722" effect="314983004: Deteriorating renal function (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="nsaids" precipitantCode="N0000175722" effect="NO MAP"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="agents that block the renin-angiotensin system" precipitantCode="n0000175561" effect="166689004: Raised serum potassium level (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="agents that block the renin-angiotensin system" precipitantCode="n0000175561" effect="166717003: Serum creatinine raised (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="amiloride" precipitantCode="N0000006772" effect="166689004: Raised serum potassium level (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="amiloride" precipitantCode="N0000006772" effect="166717003: Serum creatinine raised (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="drugs that may increase potassium levels" precipitantCode="NO MAP" effect="166689004: Raised serum potassium level (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="drugs that may increase potassium levels" precipitantCode="NO MAP" effect="166717003: Serum creatinine raised (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="heparin" precipitantCode="N0000006341" effect="166689004: Raised serum potassium level (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="heparin" precipitantCode="N0000006341" effect="166717003: Serum creatinine raised (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="potassium supplements" precipitantCode="N0000175600" effect="166689004: Raised serum potassium level (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="potassium supplements" precipitantCode="N0000175600" effect="166717003: Serum creatinine raised (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="potassium-sparing diuretics" precipitantCode="N0000175418" effect="166689004: Raised serum potassium level (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="potassium-sparing diuretics" precipitantCode="N0000175418" effect="166717003: Serum creatinine raised (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="salt substitutes containing potassium" precipitantCode="NO MAP" effect="166689004: Raised serum potassium level (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="salt substitutes containing potassium" precipitantCode="NO MAP" effect="166717003: Serum creatinine raised (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="spironolactone" precipitantCode="N0000005900" effect="166689004: Raised serum potassium level (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="spironolactone" precipitantCode="N0000005900" effect="166717003: Serum creatinine raised (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="triamterene" precipitantCode="N0000005985" effect="166689004: Raised serum potassium level (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="triamterene" precipitantCode="N0000005985" effect="166717003: Serum creatinine raised (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="potassium-sparing diuretics" precipitantCode="n0000175418" effect="166689004: Raised serum potassium level (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="potassium-sparing diuretics" precipitantCode="n0000175418" effect="166717003: Serum creatinine raised (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="salt substitutes" precipitantCode="N0000007207" effect="166689004: Raised serum potassium level (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="salt substitutes" precipitantCode="N0000007207" effect="166717003: Serum creatinine raised (finding)"/>
<LabelInteraction type="Pharmacodynamic interaction" precipitant="selective cox-2 inhibitors" precipitantCode="n0000008288" effect="NO MAP"/>

</LabelInteractions></Label>